USRE42837E1 - Spinal nucleus implant - Google Patents

Spinal nucleus implant Download PDF

Info

Publication number
USRE42837E1
USRE42837E1 US10/625,390 US62539003A USRE42837E US RE42837 E1 USRE42837 E1 US RE42837E1 US 62539003 A US62539003 A US 62539003A US RE42837 E USRE42837 E US RE42837E
Authority
US
United States
Prior art keywords
implant
spinal
nucleus
swellable
plastic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US10/625,390
Inventor
Vladimir Stoy
Gerald Gontarz, Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Replication Medical Inc
Original Assignee
Replication Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US09/410,268 priority Critical patent/US6264695B1/en
Application filed by Replication Medical Inc filed Critical Replication Medical Inc
Priority to US10/625,390 priority patent/USRE42837E1/en
Assigned to REPLICATION MEDICAL, INC. reassignment REPLICATION MEDICAL, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GONTARZ, GERALD
Application granted granted Critical
Publication of USRE42837E1 publication Critical patent/USRE42837E1/en
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/20Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2/441Joints for the spine, e.g. vertebrae, spinal discs made of inflatable pockets or chambers filled with fluid, e.g. with hydrogel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/16Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2/442Intervertebral or spinal discs, e.g. resilient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006Properties of materials and coating materials
    • A61F2002/30075Properties of materials and coating materials swellable, e.g. when wetted
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2/442Intervertebral or spinal discs, e.g. resilient
    • A61F2002/4435Support means or repair of the natural disc wall, i.e. annulus, e.g. using plates, membranes or meshes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2/442Intervertebral or spinal discs, e.g. resilient
    • A61F2002/444Intervertebral or spinal discs, e.g. resilient for replacing the nucleus pulposus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0061Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof swellable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/38Materials or treatment for tissue regeneration for reconstruction of the spine, vertebrae or intervertebral discs

Abstract

The present invention is a spinal nucleus implant for replacement of at least a portion of nucleus pulposus tissue removed from a spinal disc of a living vertebrate to restore function of the spinal disc and related vertebral joint. The implant is an anisotropically swellable, biomimetic xerogel plastic, having a two phase structure with a hydrophobic phase having high crystallinity and low water content and with hydrophilic phase having low crystallinity and high water content and having a negatively charged lubricious surface. The xerogel plastic is capable of rehydration and of osmotic movement of liquid therethrough in response to osmotic pressure change to thereby increase and decrease liquid content in its hydrated state. The present invention also relates to surgical implant procedures utilizing this spinal nucleus implant.

Description

BACKGROUND OF THE INVENTION

1. Field of the Invention

The present invention relates to a spinal nucleus implant to replace all or a portion of nucleus pulposus which has been removed form a spinal disc of a living vertebrate, e.g. a human. This spinal nucleus implant is formed of a xerogel which is capable of anisotropic swelling.

2. Information Disclosure Statement

Spinal intervertebral disc is a cartilaginous tissue located between the endplates of adjacent vertebra. The spinal intervertebral disc acts as a flexible joint between the vertebra, allowing bending and twisting of the spine column. Damage to the spinal intervertebral disc can cause spinal dysfunction, crippling pain and short- or long-term disability. Because of the wide occurrence of this problem (5% annual incidence of back pain due to the spinal intervertebral disc is reported), the economic consequences are enormous. Some disc problems require a surgery. Typical current procedure is fusion of the adjacent vertebra using various techniques and devices, such as those described in the U.S. Pat. No., 4,636,217 (Ogilvie, et al.), U.S. Pat. No. 5,489,308 (Kuslich, et al.) and U.S. Pat. No. 5,716,415 (Steffee). All currently available surgical procedures, such as removal of the nucleus or its part (laminectomy), or fusion of adjacent vertebra, compronise spinal function in one way or another.

For this reason, new remedies are being sought, including the development of prosthesis of the disc or its part. This is a difficult undertaking. The spinal column is an extremely intricate body part, and its proper function is dependent on the seamless cooperation of all its components, including the vertebral discs. A vertebral disc has to perform multiple functions. It has to withstand repeated high stresses in very complex modes of deformation including combined bending, torque, shear and compression. In addition, the spinal intervertebral disc acts as an efficient shock absorber and a pump driving a flow of nutrients into and metabolites from the disc. Structurally, the disc is a rather complex composite part involving several types of materials organized in a complex and intricate fashion. Vertebral endplates are covered by a layer of hyaline cartilage composed of a collagen matrix, a glycoprotein component, and water. In addition, about 2-5% of its volume is occupied by living cells producing the components of the cartilage.

The spinal intervertebral disc itself is composed mainly of crystalline collagen fibrils and amorphous hydrophilic proteoglycans. About 3-5% of the volume is occupied by living cells that produce the its constituents. Structurally, the spinal intervertebral disc is composed of a hydrogel-like core called the nucleus pulposus; and an outside ring called the annulus fibrosus. The structure of the spinal intervertebral disc is schematically depicted in FIG. 1 and described below.

The spinal intervertebral disc acts primarily as a weight-bearing and flexible joint. It enables mutual rotation, bending and translation of the adjacent vertebra, while bearing a considerable axial load. In addition, the spinal intervertebral disc attenuates vibrations and mechanical shocks and prevents their propagation through the skeletal system The load bearing capability and flexibility in selected directions is achieved by the combination of the annulus fibrosus and nucleus pulposus. Annulus fibrosus is a layered structure that is rigid in the radial direction but deformable in the axial direction and by torque. The axial load is born by nucleus pulposus that transforms it partly into an axial component that is contained by the annulus fibrosus. The annulus fibrosus is formed mainly by collagen fibrils organized in several layers. Each layer has its collagen fibrils wound at an angle, and subsequent layers have an alternate orientation. The collagen organization closely resembles organization of fiber reinforcement as in composites used for pressure vessels or cords in tires. It guarantees maximum resistance to radial stress (or internal pressure) while allowing a deformation in torque and bending.

The fibril ends are attached to the adjacent vertebra and to the cartilaginous surface of the vertebral endplates. Consequently, the inner space of the annulus fibrosus is virtually sealed. Any liquid penetrating in or out of the core has to pass through the annulus fibrosus tissue or through the vertebral endplates. To achieve sufficient hydraulic permeability, the collagenous structure of the annulus fibrosus is supplemented by proteoglycans embedded between the collagen fibrils. The proteoglycans are hydrated so that the annulus fibrosus forms a sort of a highly organized, anisotropic hydrogel composite. The collagen domains form a microfibrillar mesh. The result of this arrangement is a sufficient deformability in selected directions combined with high mechanical strength, and particularly high tear strength and resistance to fracture propagation that are needed for a load-bearing function.

The nucleus pulposus is connected to the annulus fibrosus, but not to the endplates. It has much a lower concentration of collagen (which concentration increases with age) and a higher concentration of hydrophilic proteoglycans. Consequently, it is a natural composite which is somewhat like a hydrogel and has a very high equilibrium water content (more than 90% by weight in young persons). The water content and volume of nucleus pulposus depends on osmolarity of swelling medium and on the mechanical pressure. The resistance to the decrease of liquid content due to mechanical pressure is called the “swelling pressure”. Swelling pressure is the very key to the function of the nucleus pulposus. As the axial load expels the liquid, the swelling pressure increases until it reaches equilibrium with the external load. Accordingly, the nucleus pulposus is capable of counterbalancing and redistributing the axial stress, converting them to radial components that can be confined by the annulus fibrosus. In addition, the dehydration and rehydration of nucleus pulposus under varying load drives the transport of metabolites and nutrients in and out the spinal intervertebral disc. Therefore, the nucleus pulposus acts as an osmotic pump facilitating transport of nutrient and metabolites to and from the spinal disc and surrounding tissues. This transport function is essential because the cartilaginous components (annulus fibrosus, nucleus pulposus and cartilaginous layer of the vertebral endplates) are neither vascularized nor can be supported with nutrition by mere diffusion.

Since the nucleus pulposus is substantially a macroscopically isotropic tissue, it has to be organized on its molecular and supermolecular levels to perform all these functions.

The nucleus pulposus structure is rather ingenious. The nucleus pulposus is constructed from a two-phase composite consisting of crystalline collagen domains forming a scaffold, and amorphous glycoprotein domains forming hydrophilic filler. The crystalline collagen domains are responsible for a relatively high strength even at high hydration. They form a microfibrillar mesh resembling the fibrous reinforcement in high-performance composites. The result of this arrangement is a sufficient deformability combined with sufficient mechanical strength even at full hydration.

The amorphous domains are responsible for water absorption and for the generation of a swelling pressure. They are formed mainly by high-molecular, water-soluble glycoproteoglycans. Glycoproteoglycans are highly hydrophilic and water-soluble polymers. A small portion of glycoaminoglycans is covalently bound to the coilagenous scaffold, turning it hydrophilic and highly wettable with water (this is necessary for the thermodynamic stability of the two-phase composite). A large portion is unattached to the scaffold and is retained by an entrapment within the scaffold due to the large size of glycoproteoglycans molecules.

To help this physical retention, glycoproteoglycans chains associate to form larger units. Glycoproteoglycans chains are equipped with protein terminal sequences adjusted for attachment to hyaluronic acid. The complexes of the hyaluronic acid and GPG are too large to escape from the collagenous scaffold. This is a very different arrangement than in hydrogels where the confinement of hydrophilic moieties is achieved by crossliking. One can surmise that the arrangement in the nucleus pulposus provides a higher osmotic pressure at a given polymer concentration than the network arrangement usual in hydrogels.

The glycoproteoglycans in the amorphous phase bear a dense negative charge. The high negative charge density is important because it generates high values of viral coefficients and, therefore, causes maximum swelling pressure at a high water content. The high charge density is facilitated by the composite structure of the nucleus pulposus. A synthetic crosslinked hydrogel with a similar charge density would be brittle and mechanically very weak.

A high negative charge is also responsible for a high surface hydration that is necessary for a low wet friction. This is important for the low-friction contact between the nucleus pulposus and the cartilaginous surfaces of vertebral end plates. A high friction would probably cause an excessive wear of the cartilage and degenerative changes in vertebra.

This structural complexity of spinal intervertebral disc is the consequence of complex requirements, not a whimsical excess of nature. Therefore, the disc replacement's function, properties and structure has to be a close approximation of the original disc in order to be able to perform all its functions. In other words, a successful disc replacement has to be biomimetic to the maximum degree achievable.

This was not possible for a long time because there were no synthetic materials that could replicate structure, properties and functions of natural tissue. Because of that, most of the prostheses were designed as mechanical joints enabling certain movement of vertebra but not replicating all SID properties. Such prostheses are described, for instance, in the following U.S. patents:

    • U.S. Pat. No. 3,875,595 (Froning); U.S. Pat. No. 4,349,921 (Kuntz); U.S. Pat. No. 4,309,777 (Patil); U.S. Pat. No. 4,714,469 (Kenna); U.S. Pat. No. 4,904,261 (Dove, et al.); U.S. Pat. No. 4,759,769 (Hedman, et al.); U.S. Pat. No. 4,863,476 (Shepperd); U.S. Pat. No. 5,053,034 (Olerud); U.S. Pat. No. 5,674,296 (Bryan, et al.); U.S. Pat. No. 5,676,701 (Yuan, et aL); U.S. Pat. No. 5,824,094 (Serhan, et al.); U.S. Pat. No. 5,865,846 (Bryan, et al).

The main problem of these devices is limited functionality. Even more importantly, implantation of these devices is a very complex procedure requiring a major spine surgery with many associated risks, long-term recovery and high cost.

There is an ongoing effort to develop better prosthesis of the disc that would more closely replicate its mechanical function. For instance, Lee et aL in the U.S. Pat. No. 4,911,718 “Functional and Biocompatible Intervertebral Spacer” (1990) describe a composite replacement of the disc made from a biocompatible elastomer reinforced with fibers that mimics the mechanical properties of the natural disc. It replicates the disc structure having an elastomeric core with the shape approximating the shape of nucleus pulposus, wrapped around by a fiber-reinforced elastomeric layers replicating structure of annulus fibrosus. The reinforcing fibers have preferred orientation-simulating arrangement of collagen fibers in annulus fibrosus. The faces of the assembly are equipped with tough elastomeric layers simulating the mechanical function of cartilaginous layers of vertebral endplates. This structure reasonably closely replicates the spinal intervertebral disc structure and its mechanical function. However, the implantation of this device is still very complex and costly, requiring a major spine surgery.

In many cases, the pain relief requires that only nucleus pulposus (or even only its part) be removed rather than whole spinal intervertebral disc. In that case, the major part of the axial load is directly applied to annulus fibrosus. Annulus fibrosus is now stressed by the axial rather than radial load for which it is designed. Consequently, annulus fibrosus delaminates, splits, fractures and brakes down gradually. The situation is somewhat akin to driving on a deflated tire. In this situation, it is useful to replace the missing nucleus pulposus (or its part) to reestablish the radial stress on annulus fibrosus (or to “reinflate” the spinal intervertebral disc) that is required for its proper function. The nucleus pulposus replacement can be carried out by an easier, less traumatic and less expensive surgical procedure.

It is important to recognize that a successful replacement of nucleus pulposus has to replicate not only the mechanical function, but also the function of osmotic pump. Without that, the living tissue of vertebral endplate cartilages and annulus fibrosus cannot be maintained in healthy condition. For those reasons, the nucleus pulposus cannot be replaced by a piece of a hydrophobic, non-hydrogel elastomer, such as silicone rubber or polyurethane.

This need to maintain the liquid transport function was first recognized by Bao et al. in the U.S. Pat. No. 5,047,055. Bao describes a hydrogel prosthesis that has, in its fully hydrated state, the shape and size generally conforming to a missing natural nucleus, i.e., to the cavity left after removal of nucleus pulposus tissue. The hydrogel used in the implant has, in its fully hydrated state, water content at least 30% and compressive strength at least 4 MN/m2 (i.e., 40 kg/cm2 or 556 psi). This high strength has to be achieved even at full hydration and at a very high water content, such as in the preferred range 70 to 90% of liquid. Conceivably, this very high requirement on mechanical strength is dictated by possible herniation of isotropic material that was implanted into damaged and weakened annulus fibrosus. This rather extreme requirement limits selection of materials useful for this device, Hydrogels are typically weaker than other plastics and rubbers, particularly at high water content. Therefore, selection of high-swelling hydrogels with such a high compressive strength is rather narrow.

The hydrogel prostheses according to Bao is implanted in partly or fully dehydrated shape when it is undersized, i.e. its volume is 10-70% of the volume of fully hydrated hydrogel implant. Consequently, the hydrogel implant can be inserted through a small incision and then grow into its full size by absorbing aqueous body fluids. The hydrogel used for the implant has in its fully hydrated state water content higher than 30%, and preferably between 70 and 90% of liquid. The materials used by Bao are isotropic so that the implant's expansion due to hydration is equal in all directions. The implant can be composed from 2 or more pieces of combined size and shape, if fully hydrated, of the cavity vacated by the nucleus pulposus removal.

There are several shortcomings of this concept. Hydrogel expansion is limited to the size of the cavity vacated by the nucleus pulposus, so that its swelling pressure at the fully hydrated and expanded state will be very low, or even zero. Therefore, the implant will not generate sufficient axial force for the vertebral separation that can be found in the healthy spinal intervertebral disc. This is different from natural nucleus pulposus that is underswelled inside the spinal intervertebral disc and generates positive swelling pressure even at maximum vertebral separation. Bao could not use such an “oversized design” because the spinal nucleus implant is implanted into a damaged annulus fibrosus (either due to surgical incision or due to the original injury) and expansion of the spinal nucleus implant beyond the cavity size would cause its extrusion similar to herniation of natural nucleus pulposus. As Bao notes, bulging of the implant under stress is prevented by resistance of annulus fibrosus to deformation. Because the integrity of annulus fibrosus is compromised, hydrogel used in prosthesis has to be much stronger than natural nucleus pulposus to resist herniation or extrusion (namely, more than 4 MN/sq.m at full hydration).

This limitation is caused by the fact that the swelling of the Bao's the spinal nucleus implant is isotropic, namely, it is the same in radial and axial directions. Consequently, extensive expansion in axial direction would cause comparable expansion in radial direction that would generate pressure against the damaged annulus fibrosus and cause it rupture, bulging or herniation. In addition, the hydrogels of the kind described by Bao are isotropic elastomers, with the same deformability in any direction. In the described design, the axial load will cause radial deformation, that will be the largest in the direction of the least resistance, i.e. in locations where annulus fibrosus has been weakened by the surgery or by previous injury to the disc. This may result in bulging, herniation or extrusion of the implant—problems similar to the disc damage that was the reason for the surgery in the first place.

Some of these shortcomings were addressed in subsequent invention by Bao et al. described in the U.S. Pat. No. 5,192,326. The prosthetic nucleus is formed by a multiplicity of hydrogel beads having water content at least 30%, said beads being surrounded by a flexible semipermeable cover. The porous cover has, if fully extended, the size and shape of the cavity vacated by the nucleus pulposus removal. The size of the beads is at least three times larger than size of the pores in said cover so that the hydrogel is safely confined within the cover. The hydrogel beads can contain as much as 99% of liquid if fully hydrated. The overall volume of the fully hydrated hydrogel beads may be greater that the volume of the cavity vacated by the nucleus pulposus removal, because casing restricts the swelling and prevents the hydrogel expansion beyond the internal volume and dimensions of the cover. The cover can be made of knitted fibers. Preferably, the casing is coated by a highly biocompatible polymer to prevent adverse reactions to the implant. However, even with a coating the microporous casing may induce a foreign body reaction, initiate protein deposition, become loci of bacterial colonization or cause other problems. The use of the cover sacrifices some advantages of hydrogels, such as high biocompatibility and surface lubricity. In addition, the beads have relatively low packing density and relatively large interstitial space fraction.

Ray et al. invented somewhat similar designs to '326. In the U.S. Pat. No. 4,772,287 Ray describes a implant into the nucleus pulposus composed of two flexible cylindrical bladders filled with a liquid, preferably a thixotropic liquid. The bladders are surrounded by strong fibrous casing, preferably combined with a biodegradable polymer that promotes tissue in growth. Optionally, the bladders are equipped by tubing for adding or withdrawing fluid. This device obviously does not replicate the shape and properties of nucleus pulposus, only attempts to simulate some of its functions. The fibrous casing is designed to facilitate integration of the implant into the residual spinal intervertebral disc tissue, causing thus partial fusion of the vertebral joint.

In the U.S. Pat. No. 4,904,260 Ray describes an improvement of his basic design in which the capsule is made of a semipermeable material and filled with an aqueous liquid containing a therapeutic material capable of a slow diffusion from the implant into the tissue.

In the U.S. Pat. No. 5,674,295 Ray describes another improvement of his basic design in which a hydrogel cylindrical body is used instead of the liquid-filled bladder. The strong fibrous casing is designed to allow more swelling in axial direction than in radial direction, allowing thus sufficient axial expansion while protecting annulus fibrosus against excessive pressure from the expanding and/or deformed hydrogel

This design is further modified in the U.S. Pat. No. 5,824,093 (continuation-in-part to the '295) where the hydrogel bodies have oval crossections and the constraining jacket designed to maintain the general shape of the hydrogel under full hydration and load.

In all Ray's designs the device is not mimicking the nucleus pulposus shape, size, properties or full function. The volume of the hydrated hydrogel is substantially smaller that the natural nucleus pulposus volume. The shape of Ray's implant differs substantially from the nucleus pulposus shape and one could anticipate certain problems with position stability of such implants. To improve the stability, porous or fibrous constraining jacket is incorporated into the residual spinal intervertebral disc tissue. However, this causes a partial fusion, and thus a partial immobilization, of the vertebral joint. The Ray's device does not fill the space designed for nucleus pulposus, which may cause a tendency to distort and to extrude the device under some conditions.

As seen from the description, no prior art invention provides a satisfactory solution to the problem of nucleus pulposus replacement, and neither teaches the present invention nor renders the present invention obvious.

Notwithstanding the prior art, the present invention is neither taught nor rendered obvious thereby.

SUMMARY OF THE INVENTION

This invention relates to a biomimetic spinal nucleus implant designed to restore the function of spinal disc and vertebral joint after a part or all of the nucleus pulposus tissue was removed from the disc of a living vertebrate, e.g. a human. The spinal nucleus implant according to this invention is a swellable plastic device capable of anisotropic swelling into a form of hydrogel implant with anisotropic deformability. The spinal nucleus implant according to the invention is implantable into spinal disc through a small incision facilitating thus the surgery, minimizing the trauma of the surgery and improving the safety of the device.

The invention also relates to the surgical implant procedure relating thereto.

BRIEF DESCRIPTION OF THE DRAWINGS

The present invention should be more fully understood when the specification herein is taken in conjunction with the drawings appended hereto wherein:

FIG. 1 shows an oblique front view of a cross section of a spinal intervertebral disc and FIG. 2 shows a front expanded cut section of annular fibers of an annulus laminate of a spinal intervertebral disc. FIGS. 3, 4, 5 and 6 show oblique front views of various steps of a present invention surgical implant procedure, showing cavity creation (nucleus pulposus removal), spinal nucleus implant insertion, unfolded and fully hydrated;

FIGS. 7, 8, 9 and 10 show oblique front views of spherical, cylindrical, helixical and ovate spinal nucleus implant; and,

FIGS. 11, 12 and 13 show front cut views of present invention spinal nucleus implant structures.

FIGS. 14-18 show alternative embodiments of the present invention.

DETAILED DESCRIPTION OF THE PRESENT INVENTION

The device according to this invention is designed to replicate the structure and material properties of natural nucleus pulposus to the extent needed to replicate all its essential functions, to achieve position stability of spinal nucleus implant implanted in a weakened annulus fibrosus, and to make spinal nucleus implant implantable through a small incision.

The preferred spinal nucleus implant according to the present invention has properties closely mimicking the essential properties of natural nucleus pulposus, such as:

    • Hydrophilic material with equilibrium water content around 90% or higher at full hydration;
    • Two-phase structure comprising domains with high crystallinity and lower water content {“hydrophobic domains”) and domains with low crystallinity and high water content (“hydrophilic domains”).
    • High content of carboxylate groups, particularly in hydrophilic domains with high water content and on the surface of the device.
    • Associative water-soluble polymers concentrated in hydrophilic domains with higher water content.
    • Water content strongly dependent on osmolarity of swelling medium.
    • Highly hydrated negatively charged lubricious surface.

The spinal nucleus implant according to the present invention also has the following differences from natural nucleus pulposus:

    • The implant size, in its fully hydrated state, does not conform to the natural nucleus pulposus;
    • The implant shape, in its fully hydrated state, does not conform to the natural nucleus pulposus;
    • Dehydrated implant has anisotropical swelling with preferred swelling in axial direction of spine (vertical plane), and suppressed in the radial direction (horizontal planes);
    • The implant has anisotropical deformability (it is more deformable axially and more rigid radially).

These features are explained in more detail below.

In order to replicate or replace the nucleus pulposus functions, the present invention spinal nucleus implant comprises a material capable of swelling in the presence of water and is capable of changing water content in response to external conditions, such as pressure, temperature, osmolarity or pH. They are two types of swellable materials suitable for this invention: More organized hydrophilic composites having some hydrophobicity resembling structure of cartilaginous tissues, and more homogeneous hydrogels.

The present invention hydrophilic composites can be of “cellular” (or “domain”) type with continuous hydrophobic domains and discrete hydrophilic domains, and interpenetrating networks where both types of domains are continuous.

The preferred material for the spinal nucleus implant is a synthetic composite of the cellular type with the structure similar to the nucleus pulposus. The structure comprises strong fibrillar crystalline phase, and an amorphous phase comprising charged associative polymers. Polymers involved in the composite are non-biodegradable, preferably with carbon-carbon backbone. The preferred types of polymers are multiblock acrylic polymers. Composites may be of “domain type”, in which associative polymers are located in discrete hydrophilic domains; or of a “interpenetrating network” type.

The requirements for the spinal nucleus implant according to the present invention can be also met by certain type of hydrogels. Contrary to composites, hydrogels are formed by a single type of network (covalent, physical or combined). Only hydrogels having certain combination of properties are suitable for the present invention, as described in more detail below.

According to the present invention, height (ie., the axial dimension) of the fully hydrated the spinal nucleus implant is greater than maximum separation between the vertebra in prone position. The fully hydrated diameter of the spinal nucleus implant, however, is substantially the same as the diameter of the cavity vacated by the nucleus pulposus removal.

In the following description, the term “swellable plastic” is used to include both composites and hydrogels.

Swellable plastics contain one or more polymeric components. Preferably, swellable plastics suitable for the spinal nucleus implant comprise polymeric components having C—C backbone. Such polymers, such as polyvinylalcohol, polyvinyl pyrrolidone or derivatives of polyacrylic or polymethacrylic acid, are more resistant to biodegradation than polymers with heteroatoms in their backbones, such as polyurethanes or polyesters.

Preferably, at least on of the polymeric components contains both hydrophilic hydrophobic groups.

The preferred swellable plastic comprises two polymer phases of different hydrophilicity, the less hydrophilic phase having higher content of hydrophobic groups and more hydrophilic phase having higher content of hydrophilic groups. The less hydrophilic phase is preferably crystalline and more hydrophilic phase is preferably amorphous, as can be established from X-ray diffraction.

The preferred hydrophobic groups are pendant nitrile substituents in 1,3 positions on polymethylene backbone, such as in poly(acrylonitrile) or poly(methacrylonitrile). The hydrophilic phase preferably contains a high concentration of ionic groups. Preferred hydrophilic groups are derivatives of acrylic acid and/or methacrylic acids including salts, acrylamidine, N-substituted acrylamidine, acrylamide and N-substituted acryl amide, as well as various combinations thereof. The particularly preferred combination contains approximately two thirds of acrylic acid and its salts (on molar basis), the rest being a combination of plain and N-substituted acrylamides and acrylamidines.

At least one polymeric component is preferably a multiblock copolymer with alternating sequences of hydrophilic and hydrophobic groups. Such sequences are usually capable of separating into two polymer phases and form strong physically crosslinked hydrogels. Such multiblock copolymers can be, for instance, products of hydrolysis or aminolysis of polyacrylonitrile or polymethacrylonitrile and copolymers thereof For the sake of brevity, we will call “PAN” all polymers and copolymers having at least 80 molar % of acrylonitrile and/or methacrylonitrile units in their composition. Hydrolysis and aminolysis of PAN and products thereof are described, for instance, in the U.S. Pat. Nos. 4,107,121; 4,331,783; 4,337,327; 4,369,294; 4,370,451; 4,379,874; 4,420,589; 4,943,618, and 5,252,692 that are incorporated by this reference.

The swellable plastic can comprise of at least two polymeric components arranged as interpenetrating network. In that case, one component is essentially a hydrophobic polymer capable of forming a reticulated crystalline fibrillar mesh or scaffold. Examples of such polymers are polyurethane, polyurea, PAN, expanded polytetrafluoroethylene, cellulose triacetate and polyvinylalcohol. The spaces between the fibrils are filed by a continuous phase of hydrophilic polymer with 3-dimensional physical or covalent network (i.e., a hydrogel such as crosslinked polyvinylalcohol or polyvinylpyrrolidone). The most suitable hydrogels for this role are those based on hydrophilic derivatives of polyacrylic and polymethacrylic acid.

The preferred material for the spinal nucleus implant is a synthetic composite of a cellular (or domain) type with continuous phase formed by a hydrophobic polymer or a hydrophilic polymer with low to medium water content forming a “closed cells” spongy structure that provides composite with a strength and shape stability. Examples of suitable polymers are polyurethanes, polyureas, PAN, polydimethylsiloxanes (silicone rubber), and highly crystalline multiblock acrylic and methacrylic copolymers. The polymer has to be sufficiently permeable for water. It is known that even distinctly hydrophobic polymers, such as silicone rubber, can form swellable composites. More preferably, the continuous phase is formed by a strong hydrophilic polymer with sufficient permeability for water but impermeable for high-molecular solutes. Examples of such polymers are highly crystalline hydrogels based on segmented polyurethanes, polyvinylalcohol or multiblock acrylonitrile copolymers with derivatives of acrylic acid. Typically, suitable polymers for the continuous phase in cellular composites have water content in fully hydrated state between about 60% by weight and 90% by weight, preferably between 70 and 85% by weight.

The second component is a highly hydrophilic polymer of high enough molecular weight that cannot permeate through the continuous phase. This component is confined inside the matrix of the continuous phase. The entrapped hydrophilic polymers may be high-molecular weight water-soluble polymers, associative water-soluble polymers or highly swellable hydrogels containing, in fully hydrated state, at least 95% of water and up to 99.8% of water. Such hydrogels are very weak mechanically. However, it does not matter in composites where such polymers' role is generation of osmotic pressure rather than load-bearing, with compression strength in full hydration in the range of 0.01 MN/m2 or lower.

Such system with closed cells (or domains) containing highly swellable or water-soluble polymers can form composites with very high swelling pressure as needed for the spinal nucleus implant function. Examples of suitable hydrophilic polymers are high-molecular weight polyacrylamide, polyacrylic acid, polyvinylpyrrolidone, polyethyleneoxide, copolymers of ethyleneoxide and propyleneoxide or hyaluronic acid; covalently crosslinked hydrogels such as hydrophilic esters or amides of polyacrylic or polymethacrylic acids; and physically crosslinked hydrogels, such as hydrolyzates or aminolyzates of PAN.

Particularly suitable are associative water-soluble polymers capable of forming very highly viscous solutions or even soft physical gels. Preferred are associative polymers containing negatively charged groups, such as carboxylates, sulpho-groups, phosphate groups or sulfate groups. Particularly preferred are associative polymers formed by hydrolysis and/or aminolysis of PAN to high but finite conversions that leave a certain number of nitrile groups (typically, between 5 and 25 molar %) unreacted.

Preferred composites have both continuous phase and dispersed phase formed by different products of hydrolysis or aminolysis of PAN. In this case both components are compatible and their hydrophobic blocks can participate in the same crystalline domains. This improves anchorage of the more hydrophilic component and prevents its extraction. Size of more hydrophilic domains may vary widely, from nanometers to millimeters, preferably from tens of nanometers to microns.

The ratio between the continuous a discrete phase (i.e., between more hydrophobic and more hydrophilic components may vary from about 1:2 to 1:100 on the dry weight basis, but preferred ratio ranges from about 1:5 to 1:20.

Any swellable plastic (e.g. a hydrogel) can be characterized in various ways. The most important characteristic is the liquid content in the state of full hydration. We use the term “Mill hydration” in the usual sense, i.e. meaning equilibrium hydration in full and unrestricted contact with an excess of a liquid of defined composition at a defined temperature, for a time sufficient to achieve equilibrium, without any restriction of sample expansion due to a limited space, availability of swelling liquid or due to an external load or pressure applied against the hydrogel. Unless specifically stated otherwise, the liquid medium is an isotonic unbuffered 0.9% by weight NaCl solution in water, and temperature is the body temperature of 36.5° C.+/−0.5° C.

Dehydrated swellable plastic is often called “xerogel”. Another characteristic is compression strength. It can be measured according to ASTM method D695, performed in aqueous immersion. Unless stated otherwise, compressive strength is meant at full hydration and ambient temperature.

Swellable plastics used in the present invention has to have the following basic characteristics:

    • Liquid content in the state of full hydration with deionized water at ambient temperature higher than 70% of water and preferably higher than 95% of water.
    • Liquid content in the state of full hydration with 0.9% aqueous solution of NaCl at body temperature higher than 65% and preferably higher than 85% of liquid.
    • Capability of anisotropical swelling, i.e. capability of a xerogel to expand due to its hydration, even in absence of an external load or any external restriction, in a selected direction or directions more than in other directions. For instance, an anisotropic xerogel rod can increase its diameter while decreasing its length due to its hydration.
    • Swellable plastics particularly useful for this invention have modulus of elasticity increasing with deformation. This is important for confinement of radial deformation, i.e. prevention of bulging and herniation under high axial loads. Swellable plastics exhibiting this type of behavior are typically those containing a crystalline phase in their structure.
    • Swellable plastics suitable for this invention are those capable of holding “frozen deformation” and to release such deformation in fully hydrated state. Such materials are often called “memory hydrogels” or “memory hydrogel composites”. Particularly useful are those materials that are able to hold the “frozen deformation” even in plasticized state at temperatures lower than body temperature. The frozen deformation is released due to hydration, heating to body temperature or a combination of both.
    • Swellable plastics particularly useful for invention are those with high hydraulic permeability. All hydrophilic plastics, including hydrogels, have relatively high diffusive permeability for water and aqueous solutes. However, the spinal nucleus implant application requires different type of permeability, so called hydraulic permeability, in which the transport is facilitated by pressure gradient rather than concentration gradient. Hydraulic permeability can be characterized by “filtration coefficient” Kf. Swellable plastic suitable for the present invention have Kf>5.10−14 [cc.cm-of-thickness/sec.cm2.(dyn/cm2)] and preferably Kf>1.10−12 [cc.cm-of-thickness/sec.cm2. (dyn/cm2)].

The spinal nucleus implant according to the invention have the following characteristics:

The spinal nucleus implant has the fully hydrated volume larger than volume cavity created by a partial or complete removal of nucleus pulposus. The volume of the spinal nucleus implant fully swelled in body fluid at body temperature is preferably by at least 5% larger, and more preferably by at least 10% larger than the volume of the cavity into which the spinal nucleus implant is implanted. The cavity volume is determined at maximum natural separation of vertebra, i.e. with the body in horizontal position.

The spinal nucleus implant according to the invention has three basic shapes:

  • inherent shape A
  • insertion shape B
  • indwelling shape C
    Inherent shape A is corresponding to the most relaxed polymer network in the state of full hydration of the swellable plastic (ie., in -the state with minimum free enthalpy). The spinal nucleus implant in the inherent shape A has cross-section area substantially equivalent to the cross-section area of the cavity vacated by the removal of nucleus pulposus tissue, and height substantial larger than height of such said cavity. (By “height” is meant the dimension substantially parallel with the spinal axis while the “cross-section area” is the area lateral to the spinal axis.) Insertion shape B is the shape of xerogel deformed in such a way that it facilitates insertion and anisotropic swelling in the preferred direction of spinal axis. The xerogel in the shape B and anisotropically dehydrated state has the shape optimized for insertion into the cavity through a small incision in the annulus fibrosus. The preferred shape is an approximate shape of a cylindrical body which length is approximately the length of the longer axis of the nucleus pulposus cross-section. In presence of body fluids and absence of an external load or other spatial restriction. The spinal nucleus implant would spontaneously change from shape B to shape A.
    In dwelling shape C is substantially the shape of the cavity created by the partial or complete removal of nucleus pulposus tissue. The spinal nucleus implant is implanted in a partly dehydrated state and in the insertion state A. Once inserted, it imbibes additional water from body fluids and increases its volume until it reaches shape C. The volume in the state C is smaller than in state A and its main dimensions are different. The spinal nucleus implant is partially dehydrated in the shape B because the restriction of space and pressure of surrounding structures does not allow xerogel to reach full hydration. In the shape C, the xerogel has reached substantially the fully hydrated cross-section of the state B. Because of that, it does generate radial swelling pressure that could overly strain the weakened annulus fibrosus and to cause extrusion or herniation. However, the height in the shape C is smaller that the fully hydrated shape A so that the spinal nucleus implant generates swelling pressure preferentially in axial direction.

Once implanted into the cavity in the disc, the spinal nucleus implant according to the present invention swells anisotropically from shape B to shape C, i.e. differently in various directions. For isotropic swelling, which is typical for hydrogels hitherto used in the spinal nucleus implant, relative increase of all linear dimension is the same, and relative increase of any dimension is cubic root of relative volume expansion. For instance, if volume of an isotropic hydrogel increases eight times due to the hydration, any of its linear dimensions (such as thickness, diameter, radius of curvature etc) is doubled.

In the case of anisotropic swelling, the volume change is achieved by preferential expansion in selected directions. More specifically, the spinal nucleus implant according to the present invention swells after implantation more in axial direction than in radial direction (with respect to the spine). It can even swell in the axial direction only, or swell in axial directions while sharing in radial direction. This anisotropic swelling in preferred direction allows generation of swelling pressure in axial direction (that is necessary for vertebral separation) without generating an excessive radial swelling pressure against annulus fibrosus. This feature allows the use of the spinal nucleus implant with fully hydrated volume larger than the cavity volume created by removal of nucleus pulposus tissue. The relative change in the axial direction is higher than the relative change in lateral direction by at least 25% and preferably by at least 100% (i.e., is preferably is twice as large).

Deformed shape B is the shape different from the inherent shape, with its cross-section minimized in order to facilitate its insertion through a small incision. The deformed state is stable as long as the spinal nucleus implant hydrogel is partly or fully dehydrated and as long as temperature is below glass transition temperature and/or melting temperature of at least one polymer phase in the hydrogel The preferred deformed shape B may be that of a flat disc that can be folded for insertion in a taco-style or rolled for insertion into an approximately cylindrical shape (“burrito style”). It can be also folded into a shape of letter M or into other convenient shapes.

The spinal nucleus implant according to the present invention can be made from one or more parts, each of the parts having anisotropic swelling of the spinal nucleus implant described above. Such parts can be individually smaller than the single-piece the spinal nucleus implant, but can be combined into a part that meets the essential the spinal nucleus implant requirements described above. Individual parts can be inserted through-a smaller incision and combined inside the spinal intervertebral disc cavity to perform the spinal nucleus implant function.

For instance, the spinal nucleus implant can be formed by a multitude of individual thin discs, each individually anisotropically swellable (i.e., increasing thickness rather than footprint). These discs are stacked inside the spinal intervertebral disc cavity. Compression during their swelling and the fact that they cannot become fully hydrated will secure sufficient adhesion between layers. The mutual position between layers can be also secured by various means such as sutures, pins, spikes, adhesive layers and so forth

The spinal nucleus implant in the shape B can be also formed by a single piece of longitudinal shape (such as a tape) that pushed inside the cavity through a small incision and “assembled” by folding or otherwise stacking to form the desired indwelling shape.

Additional advantage of compound the spinal nucleus implant shapes is improved liquid transport in and out of the device. Insertion through a small incision is facilitated by using a swellable plastic that is sufficiently deformable in the Insertion State. Because many swellable plastics are rigid or even brittle in completely dehydrated state, such plastics can be plastizied by a suitable non-toxic water-miscible liquid such as a salt solution, glycerol, polyethylene glycol, glyceroldiacetate, glycerolformal, dimethylsulfoxide and the like, alone or in combination with water. Another possibility is plastification with a limited about of water, although long-term control of appropriate water concentration can be difficult.

The spinal nucleus implant is implanted into a more o less damaged annulus fibrosus The anisotropic swelling protects the annulus fibrosus against excessive radial swelling pressure that could lead to herniation or extrusion of the spinal nucleus implant material. Additional protection can be provided by an anisotropic deformability of the spinal nucleus implant. Namely, it is desirable that the spinal nucleus implant is more deformable in axial that radial direction. This can be achieved by a multitude of ways. One way is to use a swellable plastic that increases its modulus of elasticity with deformation. This type of behavior is shown by many materials with crystalline component, such as natural rubber, tendon, cartilage, certain type of composites and interpenetrating networks.

This type of behavior can be readily detected from mechanical testing. The benefit can be further improved by radial orientation of the crystalline network in the spinal nucleus implant device made from such swellable plastics.

Another method for limiting radial deformation is in using embedded reinforcement from rigid materials, such as metals, plastics, polymeric fibers etc. Important is proper construction of the reinforcement so that it does not restrict axial deformation. Preferred is helical arrangement, such as embedded metal spring or helically wound fibers. Another possible arrangement is embedded stacked concentric rings. One of suitable reinforcement is knitted structures, e.g. vascular grafts that have similar requirements on anisotropic deformation. Such grafts are made from medically tested materials, which is another advantage. Polymeric reinforcement can be made from medical-grade polyurethanes, polyesters, polyamides and other polymers of sufficient rigidity.

The reinforcement can be advantageously made of permeable hollow fibers, preferably medical-grade hollow fibers used for extracorporeal oxygenators, kidney dialysis or hybrid organs. Such hollow fibers can improve hydraulic liquid transport that is critical for the proper the spinal nucleus implant function.

Metallic reinforcement elements, such as rings or helical springs, can be advantageously used as X-ray markers allowing monitoring of position and deformation status of the implant. They can be used either alone or in a combination with another reinforcement or another X-ray markets.

The spinal nucleus implant is intended as a life-long implant and its high biocompatibility is highly desirable. This can be achieved best by designing the spinal nucleus implant with a continuous highly hydrated surface, preferably with a high content of negatively charged groups, such as carboxylate groups. Particularly preferred is a gradiented surface with carboxylate concentration and hydration increasing from the bulk to the surface. Such surfaces are not only highly biocompatible, but also have very low wet friction as to not erode adjacent tissues, such as the hyaline cartilage of vertebral endplates. Moreover, they will prevent adhesions that could restrict the implant's movement, impede with the liquid transport and complicate the implant removal or replacement if that would become necessary. The preferred method is described in the copending U.S. Pat. No. 5,939,208 (P. Stoy: Method for Creation of Biomimetic Surfaces, issued Aug. 17, 1999).

Preferred manufacturing method comprises the following steps:

  • (1) Fabrication of the device from suitable swellable plastic. This includes operations such as casting, incorporation of reinforcement, creation of biomimetic surface layer and other operations that may be necessary for fabrication of the selected the spinal nucleus implant design
  • (2) Extraction of impurities in the state of full hydration of the spinal nucleus implant by a suitable aqueous liquid, such as distilled water or an isotonic salt solution. This step may consist of multiple operations, including swelling with an aqueous solution of a plasticizer, such as glycerol.
  • (3) Dehydration by evaporation of water to a preset degree in a deformed state. Essentially an axial pressure is applied to during the dehydration to impose the deformation. The pressure can be applied throughout the process, or only at the very end of the dehydration process. In that case the essentially dehydrated device is heated, deformed by a pressure using a suitable instrument, and cooled down. This final step is preferably carried out under clean room or even sterile conditions.
  • (4) Sterilization is carried out after or during the dehydration or deformation process.

The invention and some of the preferred embodiments is further illustrated by the following non-limiting examples.

EXAMPLES: Example 1

AQUACRYL 90MD hydrogel was purchased from GelMed International s.r.o., V Cibulkach 51, Prague 5, Czech Republic. It is described as acrylic multiblock copolymer with alternating hydrophilic and hydrophobic blocks, hydrophobic block being composed of acrylonitrile units, the hydrophilic blocks from a combination of acrylic acid, acrylamidine and acrylamide units. The molar composition polymer is reported as follows:

Acrylonitrile units 55%
Acrylic acid units 30%
Acrylamide units  9%
Acrylamidine units  6%

The hydrogel contains 98.6% by weight of liquid at fill hydration by pure water and 90.6% by weight in hydrated in an isotonic NaCl solution (0.9% by weight of NaCl in water).

Tensile strength at ambient temperature and full hydration by isotonic solution is 6 kg per square cm. If fully hydrated by water, the hydrogel is too brittle to measure its tensile or compressive strength (estimated below 1 kg/sq.cm in both cases).

AQUACRYL was supplied as 10% by weight polymer solution in sodium thiocyanate solvent (55% by weight aqueous solution).

AQUACRYL was molded in a semi-open porous mold into approximate shape (though not all its dimensions) of nucleus pulposus 71, which is shown in FIG. 14. The footprint or cross-section of nucleus pulposus is kidney-shaped with the largest dimension approximately 40 mm. If we orient this longest dimension in the direction of X-axis in orthogonal coordinates, than the largest dimension in the direction of Y-axis is approximately 20 mm. The height of the space between two vertebra occupied by nucleus pulposus (in the direction of spinal axis and Z-axis of the orthogonal system) is approximately 15 mm. These values are approximate and average. It has to be understood that dimensions of nucleus pulposus differ from disc to disc and from person to person. The height also differs appreciably with time and load applied on the disc.

The porous mold has the cross-section calculated to approximate dimensions of nucleus pulposus cross-section. Calculation was made from known volume fractions of polymer component in the starting solution and the final, fully hydrated hydrogel. The ratio of volumes of the solution to the gel is reciprocal ratio of volume fractions of the polymer in the two systems. Then the ratio of any mold dimension to the corresponding hydrogel dimension is third cube of the ratio of the corresponding volumes. The height of the mold is substantially larger than height of nucleus pulposus.

The AQUACRYL solution was fed into the mold and solidified by coagulation with excess of isotonic saline. Solidified hydrogel was demolded and thoroughly washed with isotonic solution until all sodium thiocyanate is removed.

After the washing the main fully hydrated dimensions in isotonic solution are as follows:

Length 31 mm
Width 18 mm
Height 86 mm

The specimen is cut to 25 mm sections and the dried under axial compression by an increasing load sufficient to maintain the original cross-sectional dimensions. The drying starts at ambient temperature. The drying temperature is gradually increased until reaches 100° C. and xerogel is kept at this temperature for 24 hours. Then it is cooled to ambient temperature. The pressure is maintained until the cooling is completed. Result of this process is a xerogel article of crossection approximately 32×19 mm and thickness approximately 2.5 mm. The device in xerogel state is shown in FIG. 15a as 81 while the same device after reswelling into its inherent, fully hydrated state is shown in FIG. 15b as 81b.

If this xerogel article is immersed into isotonic saline at body temperature, it fully hydrates and swells into original dimensions 31×18×25 mm. The swelling factors in individual axes are as follows: X=0.97; Y=0.95; Z=10.

Part of nucleus pulposus can be surgically removed to create cavity of crossection approximating the implant crossection. This device in its xerogel insertion state is a rigid wafer that can be inserted into the disc via a horizontal slit incision in annulus pulposus. The incision can be secured by suture. Once the implant swells for several hours, in increases it height until it runs against the upper endplate. The continuing swelling increases vertebral separation and stretches annulus pulposus into the shape and tension required for its long-term function. The implant becomes party hydrated and substantially conforms the shape of the cavity created by removal of the tissue. The device in its partly hydrated indwelling state (B) has approximate dimensions of 31×18×15 mm. The swelling factors in individual axes are as follows: X=0.97; Y=0.95; Z=6.

Example 2

AQUACRYL 80MD was acquired from the same source as the hydrogel from Example 1. This grade of AQUACRYL has the same structure and some functional groups, albeit in different proportion:

Acrylonitrile units 79.7%
Acrylic acid units 13.5%
Acrylamide units 4.1%
Acrylamidine units 2.7%

The hydrogel contains 90.3% by weight of liquid at full hydration by pure water and 79.8% by weight in hydrated in an isotonic NaCl solution (0.9% by weight of NaCl in water). Tensile strength at ambient temperature and full hydration by isotonic solution is 17.3 kg per square cm AQUACRYL 80MD was supplied as 10% by weight polymer solution in sodium thiocyanate solvent (55% by weight aqueous solution).

VISACRYL T2 associative polymer was purchased from GelMed International s.r.o., V Cibulkach 51, Prague 5, Czech Republic. It is described as acrylic multiblock copolymer with alternating hydrophilic and hydrophobic blocks, hydrophobic block being composed of acrylonitrile units, the hydrophilic blocks form a combination of acrylic acid, acrylamidine and acrylamide units. Part of the amide and amidine units is substituted with sulfoethylene groups. The molar composition polymer is reported as follows:

Acrylonitrile units 22.2%
Acrylic acid wiits 51.9%
Acrylamide units 8.5%
N-sulfoethylacrylamide units 6.6
Acrylamidine units 6.1%
N-sulfoethylacrylamidine units 4.7%

The polymer is soluble in pure water at an elevated temperature to form shear-thinning, thixotropic solutions at ambient temperature. At ambient temperature polymer does not dissolve but forms soft gels with water concentration 99.5% by weight in pure water and 97.6% by weight in isotonic saline. Polymer was supplied as a granular gel with 5% by weight of solids.

20 weight parts of VISACRYL T2 concentrate was mixed into 80 weight parts of AQUACRYL 80MD solution and mixed in a high-speed blender to form a viscous paste. The mixture was then heated to 60° C. in a closed vessel for 12 hours to remove entrapped air. The paste was filled into the mold from Example 1 and coagulated and washed as described in Example 1. The resulting hydrophilic composite has liquid content over 90% by weight and improved modulus of elasticity and swelling pressure as compared to hydrogel from Example 1. The molded article was soaked for 24 hours in a mixture of 12.5 weight parts of glycerol, 0.9 weight parts of NaCl and 86.6 weight parts of deionized water. It was then cut and dried under stress as described above. After drying, the article was conditioned for 24 hours in air of 60% relative humidity at ambient temperature. The resulting spinal nucleus implants are plasticized and deformable for easier insertion through a small incision. The xerogel implant can be rolled into the insertion shape shown into a cylindrical insertion shape shown as 91a in FIG. 16a. Once inserted into the surgically created cavity, it unfolds and starts its anisotropic expansion into a partially hydrated insertion shape. If it is fully hydrated without mechanical restrictions, it swells into its inherent shape shown as 16b. The implants have similar anisotropic, but faster swelling and higher swelling pressure than product described in Example 1.

Example 3

Hydrogel from the Example 1 was processed in the following way:

The polymer solution was diluted to 7.5% to decrease its viscosity and increase liquid content in the resulting content to 92.3% by weight of isotonic saline.

A strand of twisted polyester fibers was impregnated with the solution, wrapped helically around a lattice made from grass fibers (250 micron diameter) and inserted into the porous mold from Example 1 that was shortened to 25 mm. The mold was then filled with the diluted polymer solution and coagulated with tap water.

After demolding, glass fibers were removed from the gel. The polyester fiber reinforcement was completely embedded in the hydrogel, forming helix coaxial with the device. The reinforcement limited radial deformation of the molding. The channels facilitated drainage of liquid exuded from the hydrogel under axial pressure.

The molding was then washed with isotonic saline and soaked in mixture containing 12.5% of glycerol 0.9% of NaCl and 86.6% of pure water (all % by weight).

Plasticized hydrogel was then dried under pressure as described in Example 1. The result was a flexible wafer of elliptic crossection and thickness 3.5 mm. The wafer can be readily folded or rolled to facilitate implantation as described in Example 2. After implantation, the device swells only axially to achieve vertebral separation by swelling pressure.

It resists radial expansion under pressure, preventing thus extrusion or herniation in the case that annulus fibrosus is damaged. FIG. 17a shows the implant 101a in its fully hydrated inherent shape, where 103a is the embedded helical fibrous reinforcement in its expanded shape. FIG. 17b shows the implant in its xerogel insertion shape 101b with the fibrous reinforcement 103b in its compressed state.

Example 4

Cylindrical rod of expanded PTFE (GORTEX, Gore Associates), having diameter of 25.2 mm and porosity 45%, was used to swellable form interpenetrating network. The PTFE is axially stretched (up to 3 times) and soaked with a liquid containing 25% glycerol diacetate and 75% of monomer mixture comprising, HEMA (93.4%), EGDMA (0.5%) and methacrylic acid (6%), and dibenzoylperoxide (0.1%). Then axially compressed to 50% of its original length, and the monomers are polymerized under nitrogen at 65° C. The IPN composite can be reshaped for a convenient insertion when heated above 80° C., compressed and cooled under compression.

Swelling of the hydrogel component, outside of the PTFE matrix, in isotonic saline and at body temperature, is 73% by weight. Its compression strength in fully swollen state and outside of PTFE matrix is approximately 0.05 MN/m2. If swollen in isotonic saline, composite expands primarily in axial direction. The swollen IPN composite is more deformable in axial direction than in radial direction. The composite is very strong, resist radial expansion under axial pressure while generating sufficiently high axial swelling pressure. Its components are highly biocompatible and biostable with excellent history in long-term implants. Shape memory allows maintenance of the deformed insertion shape under ambient storage conditions. This combination of properties makes this composite article suitable for use as spinal nucleus implant.

Example 5

Polymer solution from Example 1 is cast as membrane approximately 2 mm thick. The membrane is soaked in a sodium thiocyanate solution to equilibrium and then partly dried to a pre-calculated weight. The conditions were calculated so that the final concentration of sodium thiocyanate in the swelling liquid is 45% by weight.

Furthermore, rings of 15 mm diameter are made from nickel-titanium alloy wires with a diameter of 0.75 mm. Foils are now stacked with wire ring placed between each two layers of foil. The stacked assembly is then compressed at 95° C. to cause polymer melting and fusing. After cooling and washing, a block of hydrophilic polymer with embedded ring-shaped reinforcement is formed, as shown in its fully hydrated insertion shape in its fully hydrated insertion shape in FIG. 18 where portion 111a is the hydrated polymer and 113a is the metal reinforcement. The polymer is thoroughly washed in isotonic saline and soaked in diluted glycerol and dried under pressure as described in Example 2.

Referring now to FIG. 1, there is shown a spinal intervertebral disc 1 of a living vertebrate such as a human or ape. It includes a nucleus pulposus center 11 and annulus laminates 3, 5, 7 and 9. FIG. 2 shows a flattened partial section of one annulus laminate 5 indicating fibers at a 60° angle to vertical axis 2.

FIGS. 3, 4, 5 and 6 show oblique front views of the spinal intervertebral disc of FIG. 1, in various stages of a surgical procedure of the present invention. Identical parts shown in FIG. 1 are identically numbered in these Figures.

In FIG. 3, an incision 15 has been made and damaged nucleus pulposus has been removed. Remaining nucleus pulposus is shown as area 13, adjacent to cavity 17, the space created from the removal of the damaged nucleus pulposus.

In FIG. 4, present invention spinal nucleus implant 21A is shown in its partially hydrated folded form and is inserted through incision 15 and into cavity 17. FIG. 5 shows spinal nucleus implant 21B (unfolded), located within cavity 17, and FIG. 6 shows spinal nucleus implant 21C and its fully hydrated, enlarged state, subject to volumetric and liquid content changes resulting from osmotic pressure changes, stresses, and movements described above. This spinal nucleus implant is initially formed in accordance with any of the examples set forth above.

FIGS. 7a, 7b, 8a, 8b, 9a, 9b, 10a and 10b show spinal nucleus implants of the present invention in various forms. The spinal nucleus implants of the present invention in their fully hydrated inherent shapes are shown in the form of sphere 31a, cylinder 33a, helix 35a, and ovoid 37a, respectively. The same implants in their xerogel insertion shapes are shown as biconvex lenticular disc 31b, rolled disc 33b, flattened helix 35b and folded elliptic disc 37b. All forms may include optional embedded reinforcing structures that are not shown in the drawings. FIG. 11 shows a top view of a present invention spinal nucleus implant 39, with a soft, high water content core 41 and an outer jacket with high crystalline polymer content 43. At their interface 45, an optional structural support or transition layer may be included.

FIG. 12 has a present invention spinal nucleus implant 51 with a core 53 and a jacket 55 and further includes structural support elements 57a in the core and 57b in the jacket.

FIG. 13 shows a partially cut present invention spinal nucleus implant sphere 61, cut along line AB. It has a center 63 with a low polymer content and a high water content with a gradient increasing in polymer content and decreasing in water content toward outer layer 69. For example, center 63 may contain ten percent polymer and ninety percent water and layer 65 may contain eighty percent of polymer and twenty percent water and layer 67 may contain thirty percent polymer and seventy percent water and outer surface 69 may contain even more water with a lubricious, negatively charged surface.

Obviously, numerous modifications and variations of the present invention are possible in light of the above teachings. It is therefore understood that within the scope of the appended claims, the invention may be practiced otherwise than as specifically described herein.

Claims (50)

1. A spinal nucleus implant for replacement of at least a portion of nucleus pulposus tissue removed from a spinal disc of a living vertebrate to restore function of said spinal disc and related vertebral joint, and implantable into the cavity created by said removal of nucleus pulposus tissue, which comprises:
A swellable, biomimetic plastic, having a hydrophobic phase having high crystallinity and low water content and with hydrophilic phase having low crystallinity and high water content, said biomrimetic biomimetic plastic having an inherent shape in which it has a relaxed polymer network in a state of full hydration, having an insertion shape in which it is at least partially dehydrated to a xerogel state and formable into a compacted mode for maximum efficiency of surgical insertion, and capable of anisotropic expansion due to partial rehydration in situ into an indwelling shape that substantially conforms to the size and shape of said cavity and is capable of osmotic movement of liquid therethrough in response to external pressure change to thereby increase and decrease liquid content in its hydrated state, said anisotropically swellable biomimetic plastic having preferred swelling in a vertical plane and suppressed minimal swelling or swelling in horizontal planes.
2. The spinal nucleus implant of claim 1 wherein said implant is anisotropically deformable in its said indwelling shape having preferred deformability in a vertical plane and suppressed deformability in horizontal planes under compression in the vertical plane.
3. The spinal nucleus implant of claim 1 wherein said swellable, biomimetic plastic is at least partially hydrated in its insertion xerogel state.
4. The spinal nucleus implant of claim 1 wherein said swellable, biomimetic plastic has been formed in a physiologically safe form by being plasticized with a non-toxic liquid in its insertion xerogel state.
5. The spinal nucleus implant of claim 4 wherein said non-toxic liquid is present at a concentration less than 50% by weight of the plasicized anisotropicafly anisotropically swellable, biomimnetic biomimetic plastic.
6. The spinal nucleus implant according to claim 3 wherein said non-toxic liquid is selected from the group consisting of glycerol, glycerol monoacetate, glycerol diacetate, glycerylformal, dimethyl sulfoxide, water and mixtures thereof.
7. The spinal nucleus implant according to claim 1 wherein said swellable, biomimetic plastic is a dehydrated anisotropically swellable plastic wherein both said hydrophobic phase and said hydrophilic phase each have hydrophobic and hydrophilic aspects and said hydrophobic phase is a less hydrophilic phase having higher content of hydrophobic groups and said hydrophilic phase is a less hydrophobic phase having higher content of hydrophilic groups, relative to one another.
8. The spinal nucleus implant according to claim 7 wherein said anisotropically swellable, biomimetic plastic comprises non-degradable polymer with a carbon-carbon backbone.
9. The spinal nucleus implant according to claim 7 wherein said less hydrophilic phase is a crystalline phase containing nitric groups.
10. The spinal nucleus implant according to claim 7 wherein said hydrophilic phase has hydrophilic groups which are selected from a group consisting of hydroxyl, carboxyl, carboxylate, amide, N-substituted amide, amidine and N-substituted amidine.
11. The spinal nucleus implant according to claim 1 wherein said swellable, biomimetic plastic has water content more than 70% by weight in said state of fully full hydration by deionized water.
12. The spinal nucleus implant according to claim 11 wherein said swellable, biomimnetic biomimetic plastic has water content more than 95% by weight in said state of full hydration.
13. The spinal nucleus implant according to claim 1 wherein said more hydrophilic phase is substantially discrete hydrophilic domains dispersed in a substantially continuous less hydrophilic domain.
14. The spinal nucleus implant according to claim 1 wherein both the hydrophilic phase and the hydrophobic phase are substantially continuous hydrophilic domains and hydrophobic domains forming an interpenetrating network.
15. The spinal nucleus implant according to claim 1 wherein said hydrophobic phase contains crystalline polymer phase detectable by x-ray diffraction.
16. The spinal nucleus implant according to claim 7 wherein said more hydrophobic phase is substantially discrete crystalline domains dispersed in a substantially continuous more hydrophilic domain.
17. The spinal nucleus implant according to claim 1 wherein said swellable, biomimetic plastic has hydrophilic lubricious surface.
18. The spinal nucleus implant according to claim 17 wherein said surface is formed in a gradiented manner with increasing carboxylic groups from the center of said implant towards its outer surface.
19. The spinal nucleus implant according to claim 1 wherein said implantable device has at least the two following structural components:
(a) an inner core from said swellable plastic; and,
(b) an outer jacket that is surrounding said core and made from said swellable plastic which is, in its fully hydrated state, less swellable than said inner core.
20. The spinal nucleus implant according to claim 1 including at least one reinforcing element from a substantially non-swellable material embedded in said swellable, biomimetic plastic.
21. The spinal nucleus implant according to claim 19 and further including at least one reinforcing element from a substantially non-swellable material embedded in said swellable, biomimnetic biomimetic plastic wherein said at least one reinforcing element is located between said jacket and said core.
22. The-spinal nucleus implant according to claim 20 wherein said at least one reinforcing element is made from an implantable material selected from the group consisting of metal, metal alloys, carbon, ceramics, polymer and combinations thereof.
23. The spinal nucleus implant according to claim 22 wherein said polymer is selected from a group consisting of acrylic polymer, methacrylic polymer, polyester, polyurethane, polyurea, polyolefin, halogenated polyolefin, polysaccharide, vinylic polymer, polyphosphazene and polysiloxane.
24. The spinal nucleus implant according to claim 19 wherein said inner core is adherent to and connected to said outer jacket.
25. The spinal nucleus implant according to claim 20 wherein said reinforcing element is more deformable in axial direction than in lateral direction under axial stress.
26. The spinal nucleus implant according to claim 20 wherein said reinforcing element has a general shape selected from the group consisting of helix, ring, elipsoid, cylinder and bellows.
27. A surgical implant procedure for replacing at least a portion of nucleus pulposus tissue removed from a spinal disc of a living vertebrae to restore function of said spinal disc and related vertebral joint, which comprises:
a.) creating a spinal nucleus implant in the form of an anisotropically swellable, biomimetic xerogel plastic, having a two phase structure with a hydrophobic phase having high crystallinity and low water content and with hydrophilic phase having low crystallinity and high water content, said xerogel plastic being capable of anisotropic expansion by rehydration into an inherent shape in which it has a relaxed polymer network in a state of full hydration, and being capable of osmotic movement of liquid therethrough in response to external pressure change to thereby increase and decrease liquid content in its hydrated state said anisotropically swellable biomimetic plastic having preferred swelling in a vertical plane and minimal swelling or suppressed swelling in horizontal planes;
b.) surgically removing at least a portion of nucleus pulposus tissue from a spinal disc of a living vertebrae to create a cavity; and,
c.) implanting said spinal nucleus implant into said nucleus pulposus cavity in an at least partially hydrated state.
28. The surgical implant procedure according to claim 27 wherein said spinal nucleus implant, in said fully hydrated state, has volume substantially larger than volume of said cavity vacated by the removal of nucleus pulposus tissue.
29. The surgical implant procedure according to claim 27 wherein said spinal nucleus implant, in said fully hydrated state, has a cross-section area substantially equivalent to the cross-section area of said cavity vacated by the removal of nucleus pulposus tissue, and height substantially larger than the height of said cavity, the “height” being the dimension substantial parallel with the spinal axis and “cross-section area” being the area lateral to the spinal axis.
30. The surgical implant procedure according to claim 27 wherein said xerogel plastic swells in situ substantially more in the direction of the spinal axis than in lateral direction.
31. The surgical implant procedure according to claim 27 wherein said xerogel plastic is implanted in an anisotropically dehydrated state in which its volume is less than 50% of the volume of said cavity vacated by the removal of nucleus pulposus tissue.
32. The surgical implant procedure according to claim 31 wherein said xerogel plastic in its anisotropically dehydrated state has the shape optimized for insertion into the cavity through a small incision in the annulus fibrosus, said shape being an approximate shape of a cylindrical body.
33. The surgical implant procedure according to claim 31 wherein said anisotropically dehydrated state is achieved by anisotropical deformation of said xerogel.
34. The surgical implant procedure according to claim 33 wherein said anisotropical deformation is achieved by heating the xerogel above its glass transition temperature, exposing it to deforming stress in a selected direction, and cooling it down under its glass transition temperature while still exposed to said deforming stress.
35. The surgical implant procedure according to claim 33 wherein said anisotropical deformation is achieved by forming said xerogel by drying the hydrated swellable plastic under a restraining stress, preventing shrinking of xerogel in one or more selected directions.
36. The surgical implant procedure according to claim 35 wherein said restraining stress is an external stress caused by applying pressure in axial direction during the dehydration process.
37. The surgical implant procedure according to claim 35 wherein said restraining stress is created by the presence of internally embedded structure preventing the shrinking in the direction lateral to the axis.
38. The surgical implant procedure according to claim 27 wherein said hydrated implant is under axial stress substantially more deformable in axial direction than in lateral direction.
39. A spinal disc implant which comprises an implant member dimensioned for positioning in a cavity defined between adjacent vertebrae, the cavity having a first height, the implant member comprising a swellable plastic, whereby upon at least partial hydration of the implant member, the implant member undergoes anisotropic expansion and has a capacity to swell to a second height which is greater than the first height wherein the first height and the second height are measured along a vertical axis and the implant member further defines a horizontal axis and a length extending along the horizontal axis, wherein the capacity to swell to the second height is greater than a swelling capacity along the length of the horizontal axis by at least 25%.
40. A spinal disc implant according to claim 39 wherein the cavity defined between the adjacent vertebrae is the disc space.
41. A spinal disc implant according to claim 39 wherein the implant further defines a transverse axis to the vertical axis and perpendicular to the horizontal axis, the horizontal axis and transverse axis defining a plane which is transverse to the vertical axis, the implant having a width which is measured along the transverse axis, wherein the implant has a capacity to expand the width along the transverse axis which is at least 25% greater than the expansion of length measured along the horizontal axis.
42. A spinal disc implant according to claim 41 wherein the swelling capacity of the implant member defines a cross-section area which is substantially equivalent to the cross-section area of the cavity which has been vacated by removal of nucleus pulposis tissue of a spinal disc.
43. A spinal disc implant according to claim 42 further comprising a reinforcing member which assists in limiting the increase in cross-section area of the implant member.
44. A spinal disc implant according to claim 43 wherein the reinforcing member is in a form selected from the group consisting of knitted structure, metal spring and helically wound fiber.
45. A spinal disc implant according to claim 41 wherein the length of the implant does not expand along the horizontal axis.
46. A spinal disc implant according to claim 39 wherein the swellable plastic is a hydrogel.
47. A spinal disc implant according to claim 39 wherein the implant member has a water content of more than 70% by weight.
48. A spinal disc implant according to claim 39 wherein the implant member is in the form of a xerogel which is dimensioned and configured for insertion through a small incision in an annulus fibrosus.
49. A spinal disc implant according to claim 39 wherein the volume of the implant member fully swelled in body fluid at body temperature is at least 5% larger than the volume of the cavity into which the implant is implanted.
50. A spinal disc implant according to claim 39 wherein the implant is capable of assuming three configurations:
(i) an inherent configuration assumed upon full hydration of the implant, the inherent configuration having a cross-section area which is substantially equivalent to the cross-section area of the cavity, wherein the cavity is formed by removal of nucleus pulposis tissue of a spinal disc; and the inherent configuration defining the second height;
(ii) an insertion configuration assumed upon at least partial dehydration of the implant which has a smaller volume than the inherent configuration, the insertion configuration dimensioned and configured to facilitate insertion through a small incision in an annulus fibrosus; and
(iii) an indwelling configuration assumed upon insertion of the implant into the cavity vacated by removal of nucleus pulposis tissue of a spinal disc, the indwelling configuration having a cross section area which is substantially equivalent to the cross-section area of the inherent configuration, and a height which is less than the height of the inherent configuration and which is determined by and which corresponds to the height of said cavity whereby positive swelling pressure is generated by the implant between the adjacent vertebrae to increase vertebral separation.
US10/625,390 1999-09-30 2003-07-23 Spinal nucleus implant Active USRE42837E1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US09/410,268 US6264695B1 (en) 1999-09-30 1999-09-30 Spinal nucleus implant
US10/625,390 USRE42837E1 (en) 1999-09-30 2003-07-23 Spinal nucleus implant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/625,390 USRE42837E1 (en) 1999-09-30 2003-07-23 Spinal nucleus implant

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/410,268 Reissue US6264695B1 (en) 1999-09-30 1999-09-30 Spinal nucleus implant

Publications (1)

Publication Number Publication Date
USRE42837E1 true USRE42837E1 (en) 2011-10-11

Family

ID=23623986

Family Applications (4)

Application Number Title Priority Date Filing Date
US09/410,268 Active US6264695B1 (en) 1999-09-30 1999-09-30 Spinal nucleus implant
US09/853,002 Active US6726721B2 (en) 1999-09-30 2001-05-10 Hydrogel-based prosthetic device for replaceing at least a part of the nucleus of a spinal disc
US10/625,390 Active USRE42837E1 (en) 1999-09-30 2003-07-23 Spinal nucleus implant
US10/830,578 Expired - Fee Related US7204897B2 (en) 1999-09-30 2004-04-23 Hydrogel-based prosthetic device for replacing at least a part of the nucleus of a spinal disc

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US09/410,268 Active US6264695B1 (en) 1999-09-30 1999-09-30 Spinal nucleus implant
US09/853,002 Active US6726721B2 (en) 1999-09-30 2001-05-10 Hydrogel-based prosthetic device for replaceing at least a part of the nucleus of a spinal disc

Family Applications After (1)

Application Number Title Priority Date Filing Date
US10/830,578 Expired - Fee Related US7204897B2 (en) 1999-09-30 2004-04-23 Hydrogel-based prosthetic device for replacing at least a part of the nucleus of a spinal disc

Country Status (9)

Country Link
US (4) US6264695B1 (en)
EP (1) EP1231868B8 (en)
JP (1) JP4347539B2 (en)
AT (1) AT512643T (en)
AU (1) AU768903B2 (en)
CA (1) CA2388794C (en)
CZ (1) CZ20021137A3 (en)
ES (1) ES2367626T3 (en)
WO (1) WO2001022902A2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100222881A1 (en) * 2008-10-03 2010-09-02 Ann Prewett Vessel protection device
US20110224790A1 (en) * 2009-09-11 2011-09-15 Articulinx, Inc. Disc-based orthopedic devices
US20120116514A1 (en) * 2002-11-05 2012-05-10 Kuslich Stephen D Semi-biological intervertebral disc replacement system
US20120232575A1 (en) * 2006-06-12 2012-09-13 Wirtel Iii Anthony Inflatable multi-chambered devices and methods of treatment using the same
US20130282121A1 (en) * 2012-03-22 2013-10-24 Ann Prewett Spinal facet augmentation implant and method

Families Citing this family (349)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050027004A1 (en) * 1993-06-09 2005-02-03 Martek Biosciences Corporation Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
US7879095B2 (en) * 1994-03-18 2011-02-01 Madhavan Pisharodi Method of inserting, rotating and releasing a spring-loaded artificial disk
WO1998020939A2 (en) 1996-11-15 1998-05-22 Advanced Bio Surfaces, Inc. Biomaterial system for in situ tissue repair
EP1056413A4 (en) * 1998-02-27 2003-08-20 Bioelastics Res Ltd Injectable implants for tissue augmentation and restoration
US7087082B2 (en) * 1998-08-03 2006-08-08 Synthes (Usa) Bone implants with central chambers
US7476250B1 (en) * 1999-04-06 2009-01-13 Mansmann Kevin A Semi-permeable membranes to assist in cartilage repair
US20030040800A1 (en) * 2000-04-26 2003-02-27 Li Lehmann K. Apparatus and method for replacing the nucleus pulposus of an intervertebral disc or for replacing an entire intervertebral disc
US7273497B2 (en) 1999-05-28 2007-09-25 Anova Corp. Methods for treating a defect in the annulus fibrosis
US20070038231A1 (en) 1999-05-28 2007-02-15 Ferree Bret A Methods and apparatus for treating disc herniation and preventing the extrusion of interbody bone graft
US6969404B2 (en) * 1999-10-08 2005-11-29 Ferree Bret A Annulus fibrosis augmentation methods and apparatus
US20060247665A1 (en) 1999-05-28 2006-11-02 Ferree Bret A Methods and apparatus for treating disc herniation and preventing the extrusion of interbody bone graft
FR2797179B1 (en) * 1999-08-03 2002-03-08 Michel Gau Prothese nuclear INTERVERTEBRAL and surgical implantation process
US6645247B2 (en) * 1999-10-08 2003-11-11 Bret A. Ferree Supplementing engineered annulus tissues with autograft of allograft tendons
US20040186573A1 (en) * 1999-10-08 2004-09-23 Ferree Bret A. Annulus fibrosis augmentation methods and apparatus
US20040024465A1 (en) * 1999-08-18 2004-02-05 Gregory Lambrecht Devices and method for augmenting a vertebral disc
US7220281B2 (en) 1999-08-18 2007-05-22 Intrinsic Therapeutics, Inc. Implant for reinforcing and annulus fibrosis
US20040044412A1 (en) * 1999-08-18 2004-03-04 Gregory Lambrecht Devices and method for augmenting a vertebral disc
US6821276B2 (en) * 1999-08-18 2004-11-23 Intrinsic Therapeutics, Inc. Intervertebral diagnostic and manipulation device
US7553329B2 (en) 1999-08-18 2009-06-30 Intrinsic Therapeutics, Inc. Stabilized intervertebral disc barrier
US6936072B2 (en) * 1999-08-18 2005-08-30 Intrinsic Therapeutics, Inc. Encapsulated intervertebral disc prosthesis and methods of manufacture
US7998213B2 (en) 1999-08-18 2011-08-16 Intrinsic Therapeutics, Inc. Intervertebral disc herniation repair
EP1624832A4 (en) 1999-08-18 2008-12-24 Intrinsic Therapeutics Inc Devices and method for augmenting a vertebral disc nucleus
JP4247519B2 (en) * 1999-08-18 2009-04-02 イントリンジック セラピューティックス インコーポレイテッド Apparatus and method for the nucleus pulposus augmentation and retention
US7717961B2 (en) * 1999-08-18 2010-05-18 Intrinsic Therapeutics, Inc. Apparatus delivery in an intervertebral disc
US6264695B1 (en) * 1999-09-30 2001-07-24 Replication Medical, Inc. Spinal nucleus implant
US20030040796A1 (en) * 1999-10-08 2003-02-27 Ferree Bret A. Devices used to treat disc herniation and attachment mechanisms therefore
US7201774B2 (en) * 1999-10-08 2007-04-10 Ferree Bret A Artificial intervertebral disc replacements incorporating reinforced wall sections
US8679180B2 (en) * 1999-10-08 2014-03-25 Anova Corporation Devices used to treat disc herniation and attachment mechanisms therefore
US7291171B2 (en) * 2002-05-10 2007-11-06 Ferree Bret A Artificial disc replacement (ADR) using elastic tether member
US7004970B2 (en) 1999-10-20 2006-02-28 Anulex Technologies, Inc. Methods and devices for spinal disc annulus reconstruction and repair
US20030153976A1 (en) 1999-10-20 2003-08-14 Cauthen Joseph C. Spinal disc annulus reconstruction method and spinal disc annulus stent
US6592625B2 (en) 1999-10-20 2003-07-15 Anulex Technologies, Inc. Spinal disc annulus reconstruction method and spinal disc annulus stent
US8632590B2 (en) 1999-10-20 2014-01-21 Anulex Technologies, Inc. Apparatus and methods for the treatment of the intervertebral disc
US7951201B2 (en) 1999-10-20 2011-05-31 Anulex Technologies, Inc. Method and apparatus for the treatment of the intervertebral disc annulus
US7052516B2 (en) 1999-10-20 2006-05-30 Anulex Technologies, Inc. Spinal disc annulus reconstruction method and deformable spinal disc annulus stent
US8163022B2 (en) 2008-10-14 2012-04-24 Anulex Technologies, Inc. Method and apparatus for the treatment of the intervertebral disc annulus
US8128698B2 (en) 1999-10-20 2012-03-06 Anulex Technologies, Inc. Method and apparatus for the treatment of the intervertebral disc annulus
US7615076B2 (en) 1999-10-20 2009-11-10 Anulex Technologies, Inc. Method and apparatus for the treatment of the intervertebral disc annulus
US7935147B2 (en) 1999-10-20 2011-05-03 Anulex Technologies, Inc. Method and apparatus for enhanced delivery of treatment device to the intervertebral disc annulus
DE60033055D1 (en) * 1999-12-06 2007-03-08 Warsaw Orthopedic Inc Intervertebral disc treatment device
US6899716B2 (en) * 2000-02-16 2005-05-31 Trans1, Inc. Method and apparatus for spinal augmentation
US7727263B2 (en) 2000-02-16 2010-06-01 Trans1, Inc. Articulating spinal implant
AR027685A1 (en) 2000-03-22 2003-04-09 Synthes Ag Fabric form and method for doing
US9314339B2 (en) * 2000-03-27 2016-04-19 Formae, Inc. Implants for replacing cartilage, with negatively-charged hydrogel surfaces and flexible matrix reinforcement
US6689125B1 (en) 2000-04-04 2004-02-10 Spinalabs, Llc Devices and methods for the treatment of spinal disorders
AT390099T (en) * 2000-04-04 2008-04-15 Link Spine Group Inc Intervertebral plastic implant
US6402750B1 (en) * 2000-04-04 2002-06-11 Spinlabs, Llc Devices and methods for the treatment of spinal disorders
US6805695B2 (en) 2000-04-04 2004-10-19 Spinalabs, Llc Devices and methods for annular repair of intervertebral discs
US6723335B1 (en) * 2000-04-07 2004-04-20 Jeffrey William Moehlenbruck Methods and compositions for treating intervertebral disc degeneration
US8622739B2 (en) * 2001-05-09 2014-01-07 Ben-Zion Karmon Method for enlarging a jaw bone using a hollow dental implant having a side perforation
US7771482B1 (en) * 2000-05-09 2010-08-10 Ben-Zion Karmon Method for tissue expansion and regeneration using bioresorbable inflatable devices
JP2004521666A (en) * 2000-08-28 2004-07-22 アドバンスト バイオ サーフェイシズ,インコーポレイティド Method and system for enhancing mammalian joints
US6620196B1 (en) * 2000-08-30 2003-09-16 Sdgi Holdings, Inc. Intervertebral disc nucleus implants and methods
US20020026244A1 (en) * 2000-08-30 2002-02-28 Trieu Hai H. Intervertebral disc nucleus implants and methods
US7674259B2 (en) * 2000-12-09 2010-03-09 Tsunami Medtech Medical instruments and techniques for thermally-mediated therapies
AU9358101A (en) * 2000-09-26 2002-04-08 Lionel C Sevrain Inter-vertebral disc prosthesis for lumbar rachis through posterior surgery thereof
US6579291B1 (en) 2000-10-10 2003-06-17 Spinalabs, Llc Devices and methods for the treatment of spinal disorders
ES2358498T3 (en) * 2000-10-24 2011-05-11 Cryolife, Inc. Bioprosthetic filling and methods, particularly for the in situ formation of intervertebral discs bioprosthesis.
JP2004515311A (en) * 2000-10-25 2004-05-27 エスディージーアイ・ホールディングス・インコーポレーテッド Intervertebral body fusion device to extend vertically
US6613089B1 (en) * 2000-10-25 2003-09-02 Sdgi Holdings, Inc. Laterally expanding intervertebral fusion device
AU2001297782B2 (en) * 2000-11-07 2006-03-02 Cryolife Inc Expandable foam-like biomaterials and methods
US6692528B2 (en) * 2000-11-09 2004-02-17 The Polymer Technology Group Incorporated Devices that change size/shape via osmotic pressure
US6776800B2 (en) * 2001-02-28 2004-08-17 Synthes (U.S.A.) Implants formed with demineralized bone
US20110212152A1 (en) * 2001-02-28 2011-09-01 Ditizio Valerio Modified anti-microbial surfaces, devices and methods
US6478822B1 (en) * 2001-03-20 2002-11-12 Spineco, Inc. Spherical spinal implant
US8679179B2 (en) * 2002-10-03 2014-03-25 Anova Corp. Annular repair devices and methods
WO2002085262A1 (en) * 2001-04-24 2002-10-31 Galley Geoffrey H Surgical restoration of an intervertebral disc
EP1560546A2 (en) * 2002-11-12 2005-08-10 Regenex Ltd. Expandable devices and methods for tissue expansion, regenerationand fixation
AU2001273767B2 (en) * 2001-06-27 2006-02-23 Synthes Gmbh Intervertebral disk prosthesis
US8715312B2 (en) * 2001-07-20 2014-05-06 Microvention, Inc. Aneurysm treatment device and method of use
US8252040B2 (en) 2001-07-20 2012-08-28 Microvention, Inc. Aneurysm treatment device and method of use
US7572288B2 (en) 2001-07-20 2009-08-11 Microvention, Inc. Aneurysm treatment device and method of use
US20040024463A1 (en) * 2001-08-27 2004-02-05 Thomas James C. Expandable implant for partial disc replacement and reinforcement of a disc partially removed in a discectomy and for reduction and maintenance of alignment of cancellous bone fractures and methods and apparatuses for same
US6736815B2 (en) * 2001-09-06 2004-05-18 Core Medical, Inc. Apparatus and methods for treating spinal discs
DE60232893D1 (en) * 2001-10-02 2009-08-20 Rex Medical Lp implant
US6783721B2 (en) * 2001-10-30 2004-08-31 Howmedica Osteonics Corp. Method of making an ion treated hydrogel
US6572653B1 (en) * 2001-12-07 2003-06-03 Rush E. Simonson Vertebral implant adapted for posterior insertion
US6761723B2 (en) * 2002-01-14 2004-07-13 Dynamic Spine, Inc. Apparatus and method for performing spinal surgery
DK175391B1 (en) * 2002-02-13 2004-09-20 Danfoss As An implant for the spine and the process for its preparation
AR038680A1 (en) * 2002-02-19 2005-01-26 Synthes Ag intervertebral implant
US20030195630A1 (en) * 2002-04-10 2003-10-16 Ferree Bret A. Disc augmentation using materials that expand in situ
US20030195631A1 (en) * 2002-04-12 2003-10-16 Ferree Bret A. Shape-memory spacers for artificial disc replacements
US8696749B2 (en) 2002-04-25 2014-04-15 Blackstone Medical, Inc. Artificial intervertebral disc
WO2003090650A1 (en) * 2002-04-25 2003-11-06 Blackstone Medical, Inc. Artificial intervertebral disc
US7001433B2 (en) * 2002-05-23 2006-02-21 Pioneer Laboratories, Inc. Artificial intervertebral disc device
US8388684B2 (en) 2002-05-23 2013-03-05 Pioneer Signal Technology, Inc. Artificial disc device
US20040049283A1 (en) * 2002-06-04 2004-03-11 Tushar Patel Medical implant and method of reducing back pain
US6793678B2 (en) 2002-06-27 2004-09-21 Depuy Acromed, Inc. Prosthetic intervertebral motion disc having dampening
US6723097B2 (en) * 2002-07-23 2004-04-20 Depuy Spine, Inc. Surgical trial implant
US7745532B2 (en) * 2002-08-02 2010-06-29 Cambridge Polymer Group, Inc. Systems and methods for controlling and forming polymer gels
US20100063174A1 (en) * 2004-02-04 2010-03-11 Ruberti Jeffrey W Systems and methods for controlling and forming polymer gels
US7485670B2 (en) * 2002-08-02 2009-02-03 Cambridge Polymer Group, Inc. Systems and methods for controlling and forming polymer gels
US20040054413A1 (en) * 2002-09-16 2004-03-18 Howmedica Osteonics Corp. Radiovisible hydrogel intervertebral disc nucleus
KR101095771B1 (en) * 2002-09-18 2011-12-21 워쏘우 오르쏘페딕 인코포레이티드 Natural tissue devices and methods of implantation
US7744651B2 (en) * 2002-09-18 2010-06-29 Warsaw Orthopedic, Inc Compositions and methods for treating intervertebral discs with collagen-based materials
JP2006515765A (en) * 2002-11-15 2006-06-08 エスディージーアイ・ホールディングス・インコーポレーテッド Collagen-based materials and methods for the treatment of synovial joint
US20040054414A1 (en) * 2002-09-18 2004-03-18 Trieu Hai H. Collagen-based materials and methods for augmenting intervertebral discs
EP1549260B1 (en) 2002-09-19 2010-01-20 Malan De Villiers Intervertebral prosthesis
AT462383T (en) * 2002-09-24 2010-04-15 Bogomir Gorensek Stabilizing device for intervertebral discs and methods for
WO2004032987A1 (en) * 2002-10-11 2004-04-22 Cartificial A/S Medical device comprising a bio-compatible polymeric product with a layered structure
WO2004043271A1 (en) * 2002-11-08 2004-05-27 Sdgi Holdings, Inc. Transpedicular intervertebral disk access methods and devices
US7828804B2 (en) * 2002-11-08 2010-11-09 Warsaw Orthopedic, Inc. Transpedicular intervertebral disk access methods and devices
US7004971B2 (en) * 2002-12-31 2006-02-28 Depuy Acromed, Inc. Annular nucleus pulposus replacement
US7101398B2 (en) * 2002-12-31 2006-09-05 Depuy Acromed, Inc. Prosthetic facet joint ligament
EP1594421A4 (en) * 2003-01-17 2006-02-08 Psinergi Corp Artificial nucleus pulposus and method of injecting same
KR20050092795A (en) * 2003-01-31 2005-09-22 짐머 오르쏘바이올로직스 인코포레이티드 Hydrogel compositions comprisign nucleus pulposus tissue
JP4275699B2 (en) 2003-01-31 2009-06-10 スパイナルモーション, インコーポレイテッド Intervertebral prosthesis deployment instrument
EP1587437B1 (en) 2003-01-31 2013-02-27 Spinalmotion, Inc. Spinal midline indicator
JP4977323B2 (en) 2003-02-06 2012-07-18 ジンテーズ ゲゼルシャフト ミト ベシュレンクテル ハフツング Intervertebral implant
JP2006517842A (en) 2003-02-14 2006-08-03 デピュイ スパイン、インコーポレイテッドDepuy Spine,Inc. Apparatus and method for in situ formation type intervertebral fusion
US20060015182A1 (en) * 2003-02-25 2006-01-19 Tsou Paul M Patch material for intervertebral disc annulus defect repair
US7824444B2 (en) * 2003-03-20 2010-11-02 Spineco, Inc. Expandable spherical spinal implant
US7819903B2 (en) 2003-03-31 2010-10-26 Depuy Spine, Inc. Spinal fixation plate
WO2004089240A2 (en) * 2003-04-04 2004-10-21 Theken Disc, Llc Artificial disc prosthesis
US6969405B2 (en) * 2003-04-23 2005-11-29 Loubert Suddaby Inflatable intervertebral disc replacement prosthesis
WO2004098420A2 (en) 2003-05-06 2004-11-18 Replication Medical, Inc. Fiber implant system for soft tissue augmentation
US6966931B2 (en) * 2003-05-21 2005-11-22 Tain-Yew Shi Artificial intervertebral disc with reliable maneuverability
US10052211B2 (en) 2003-05-27 2018-08-21 Simplify Medical Pty Ltd. Prosthetic disc for intervertebral insertion
WO2004105638A2 (en) 2003-05-27 2004-12-09 Spinalmotion, Inc. Prosthetic disc for intervertebral insertion
WO2004107955A2 (en) * 2003-05-30 2004-12-16 Teitelbaum George P Methods and devices for transpedicular discectomy
CA2527964A1 (en) * 2003-06-02 2004-12-16 Sdgi Holdings, Inc. Intervertebral disc implants and methods for manufacturing and using same
US6984246B2 (en) * 2003-06-06 2006-01-10 Tain-Yew Shi Artificial intervertebral disc flexibly oriented by spring-reinforced bellows
EP1638485B1 (en) 2003-06-20 2011-03-02 Intrinsic Therapeutics, Inc. Device for delivering an implant through an annular defect in an intervertebral disc
US20050043796A1 (en) * 2003-07-01 2005-02-24 Grant Richard L. Spinal disc nucleus implant
NL1023926C2 (en) * 2003-07-15 2005-01-18 Univ Groningen A prosthesis on the basis of a fiber-reinforced hydrogel and method for the manufacture of the prosthesis and its use.
US7537788B2 (en) * 2003-07-25 2009-05-26 Rubicor Medical, Inc. Post-biopsy cavity treatment implants and methods
US20050020899A1 (en) * 2003-07-25 2005-01-27 Rubicor Medical, Inc. Post-biopsy cavity treatmetn implants and methods
US7744852B2 (en) 2003-07-25 2010-06-29 Rubicor Medical, Llc Methods and systems for marking post biopsy cavity sites
US7153325B2 (en) * 2003-08-01 2006-12-26 Ultra-Kinetics, Inc. Prosthetic intervertebral disc and methods for using the same
WO2005013852A2 (en) * 2003-08-07 2005-02-17 Dynamic Spine, Inc. Intervertebral prosthetic device and associated devices and methods for implanting the intervertebral prosthetic device
US7309359B2 (en) * 2003-08-21 2007-12-18 Warsaw Orthopedic, Inc. Allogenic/xenogenic implants and methods for augmenting or repairing intervertebral discs
US7226482B2 (en) * 2003-09-02 2007-06-05 Synthes (U.S.A.) Multipiece allograft implant
US20050055099A1 (en) * 2003-09-09 2005-03-10 Ku David N. Flexible spinal disc
WO2005034781A1 (en) * 2003-09-29 2005-04-21 Promethean Surgical Devices Llc Devices and methods for spine repair
US8496660B2 (en) 2003-10-17 2013-07-30 K2M, Inc. Systems, devices and apparatuses for bony fixation and disk repair and replacement and methods related thereto
EP1523963B1 (en) * 2003-10-17 2007-12-12 Co-Ligne AG Fusion implant
WO2005037082A2 (en) 2003-10-17 2005-04-28 Highgate Orthorpedics, Inc. Systems, devices and apparatuses for bony fixation and disk repair and replacement and methods related thereto
US20050116400A1 (en) * 2003-11-14 2005-06-02 White Moreno J. Non-linear fiber/matrix architecture
US7691146B2 (en) 2003-11-21 2010-04-06 Kyphon Sarl Method of laterally inserting an artificial vertebral disk replacement implant with curved spacer
US20050209603A1 (en) * 2003-12-02 2005-09-22 St. Francis Medical Technologies, Inc. Method for remediation of intervertebral disks
DE502004010737D1 (en) * 2003-12-09 2010-03-25 Biedermann Motech Gmbh Height-adjustable intervertebral implant
JP4199653B2 (en) * 2003-12-09 2008-12-17 Hoya株式会社 Bone substitute material
AU2005213499B2 (en) 2004-02-06 2010-09-02 Georgia Tech Research Corporation Surface directed cellular attachment
WO2005077304A1 (en) 2004-02-06 2005-08-25 Georgia Tech Research Corporation Load bearing biocompatible device
US8945223B2 (en) * 2004-03-12 2015-02-03 Warsaw Orthopedic, Inc. In-situ formable nucleus pulposus implant with water absorption and swelling capability
US8480742B2 (en) * 2005-08-02 2013-07-09 Perumala Corporation Total artificial disc
US20050209602A1 (en) * 2004-03-22 2005-09-22 Disc Dynamics, Inc. Multi-stage biomaterial injection system for spinal implants
AT506919T (en) * 2004-03-26 2011-05-15 Nuvasive Inc Disc prosthesis
US7282165B2 (en) * 2004-04-27 2007-10-16 Howmedica Osteonics Corp. Wear resistant hydrogel for bearing applications
CA2567707C (en) 2004-05-21 2013-01-29 Synthes (U.S.A.) Replacement of nucleus pulposus using a hydrogel
US20050273172A1 (en) * 2004-06-07 2005-12-08 Patil Arun A Artificial disc and uses therefor
EP1614402A1 (en) * 2004-07-09 2006-01-11 Paul M. Tsou Patch material for inervertebral disc annulus defect repair
US7575599B2 (en) 2004-07-30 2009-08-18 Spinalmotion, Inc. Intervertebral prosthetic disc with metallic core
US7585326B2 (en) 2004-08-06 2009-09-08 Spinalmotion, Inc. Methods and apparatus for intervertebral disc prosthesis insertion
US20060036241A1 (en) * 2004-08-11 2006-02-16 Tzony Siegal Spinal surgery system and method
AU2005279772A1 (en) 2004-08-30 2006-03-09 Spineovations, Inc. Method of treating spinal internal disk derangement
CA2578110A1 (en) * 2004-08-30 2006-03-09 Neville Alleyne Method of using an implant for treatment of ligaments and tendons
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
EP1796603A2 (en) * 2004-09-23 2007-06-20 Akiva Raphael Katz Inter-vertebral disc prosthesis
US20090088846A1 (en) * 2007-04-17 2009-04-02 David Myung Hydrogel arthroplasty device
US20060095134A1 (en) * 2004-10-28 2006-05-04 Sdgi Holdings, Inc. Materials, devices and methods for implantation of transformable implants
US7799078B2 (en) * 2004-11-12 2010-09-21 Warsaw Orthopedic, Inc. Implantable vertebral lift
EP1890649A4 (en) * 2004-11-30 2011-03-30 Mansmann Kevin A Anchoring systems and interfaces for flexible surgical implants for replacing cartilage
WO2006062816A2 (en) * 2004-12-06 2006-06-15 Eastman Chemical Company Polyester based cobalt concentrates for oxygen scavenging compositions
AU2005316274A1 (en) 2004-12-16 2006-06-22 Replication Medical, Inc. Radially compressed dehydrated spinal nucleus implants
US20060195191A1 (en) * 2005-01-08 2006-08-31 Alphaspine Inc. Modular disc device
US8083797B2 (en) 2005-02-04 2011-12-27 Spinalmotion, Inc. Intervertebral prosthetic disc with shock absorption
US7591853B2 (en) * 2005-03-09 2009-09-22 Vertebral Technologies, Inc. Rail-based modular disc nucleus prosthesis
US7857856B2 (en) * 2005-03-15 2010-12-28 Warsaw Ortho Pedic, Inc. Composite spinal nucleus implant with water absorption and swelling capabilities
US20060235523A1 (en) * 2005-04-19 2006-10-19 Sdgi Holdings, Inc. Implant having a sheath with a motion-limiting attribute
US20060235525A1 (en) * 2005-04-19 2006-10-19 Sdgi Holdings, Inc. Composite structure for biomedical implants
US7674296B2 (en) 2005-04-21 2010-03-09 Globus Medical, Inc. Expandable vertebral prosthesis
US7182783B2 (en) * 2005-04-25 2007-02-27 Sdgi Holdings, Inc. Selectively expandable composite structures for spinal arthroplasty
US20060241759A1 (en) * 2005-04-25 2006-10-26 Sdgi Holdings, Inc. Oriented polymeric spinal implants
US20060247781A1 (en) * 2005-04-29 2006-11-02 Sdgi Holdings, Inc. Implant
US20060247776A1 (en) * 2005-05-02 2006-11-02 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for augmenting intervertebral discs
US20060253198A1 (en) * 2005-05-03 2006-11-09 Disc Dynamics, Inc. Multi-lumen mold for intervertebral prosthesis and method of using same
JP4857437B2 (en) 2005-06-13 2012-01-18 日本メディカルマテリアル株式会社 Nucleus for a spinal disc replacement material and manufacturing method thereof
US7601172B2 (en) * 2005-06-15 2009-10-13 Ouroboros Medical, Inc. Mechanical apparatus and method for artificial disc replacement
AU2006261357A1 (en) * 2005-06-17 2006-12-28 Zimmer Spine Austin, Inc. Improved method of treating degenerative spinal disorders
DE102005028887A1 (en) * 2005-06-22 2007-01-04 Tutogen Medical Gmbh Implant for correction of position of vertebral canal, comprises upper and lower part and made of bone substance
US20070010889A1 (en) * 2005-07-06 2007-01-11 Sdgi Holdings, Inc. Foldable nucleus replacement device
US7666227B2 (en) 2005-08-16 2010-02-23 Benvenue Medical, Inc. Devices for limiting the movement of material introduced between layers of spinal tissue
US8366773B2 (en) 2005-08-16 2013-02-05 Benvenue Medical, Inc. Apparatus and method for treating bone
US7731753B2 (en) 2005-09-01 2010-06-08 Spinal Kinetics, Inc. Prosthetic intervertebral discs
US20070050032A1 (en) 2005-09-01 2007-03-01 Spinal Kinetics, Inc. Prosthetic intervertebral discs
JP2009506843A (en) 2005-09-01 2009-02-19 スパイナル カネティックス, インコーポレイテッド Artificial disc
US20070074980A1 (en) * 2005-09-02 2007-04-05 Bankoski Brian R Implant rehydration packages and methods of use
US20070073397A1 (en) * 2005-09-15 2007-03-29 Mckinley Laurence M Disc nucleus prosthesis and its method of insertion and revision
US20070083210A1 (en) * 2005-09-16 2007-04-12 Zimmer Spine, Inc. Apparatus and method for minimally invasive spine surgery
EP1767161A1 (en) * 2005-09-22 2007-03-28 Zimmer Spine, Inc. Spinal fixation rod contouring system
JP4740337B2 (en) 2005-09-22 2011-08-03 ブラックストーン メディカル,インコーポレイティド Artificial disc
US20070083200A1 (en) * 2005-09-23 2007-04-12 Gittings Darin C Spinal stabilization systems and methods
CA2634176A1 (en) * 2005-10-26 2007-05-03 Biocure, Inc. Hydrogel spinal disc implants with swellable articles
US20070093906A1 (en) * 2005-10-26 2007-04-26 Zimmer Spine, Inc. Nucleus implant and method
EP1954215A4 (en) * 2005-11-21 2012-12-19 Nicast Ltd Spinal nucleus prosthesis device
US20070118218A1 (en) * 2005-11-22 2007-05-24 Hooper David M Facet joint implant and procedure
US7972337B2 (en) 2005-12-28 2011-07-05 Intrinsic Therapeutics, Inc. Devices and methods for bone anchoring
GB0600336D0 (en) * 2006-01-09 2006-02-15 Isis Innovation Composition and uses thereof
US7799079B2 (en) * 2006-01-18 2010-09-21 Zimmer Spine, Inc. Vertebral fusion device and method
US7662183B2 (en) * 2006-01-24 2010-02-16 Timothy Haines Dynamic spinal implants incorporating cartilage bearing graft material
US8603171B2 (en) 2006-01-25 2013-12-10 Mimedx Group, Inc. Spinal disc implants with flexible keels and methods of fabricating implants
US8038920B2 (en) 2006-01-25 2011-10-18 Carticept Medical, Inc. Methods of producing PVA hydrogel implants and related devices
US20070191956A1 (en) * 2006-02-10 2007-08-16 Replication Medical, Inc. Radially extended support member for spinal nucleus implants and methods of use
US20070233252A1 (en) * 2006-02-23 2007-10-04 Kim Daniel H Devices, systems and methods for treating intervertebral discs
US20070203580A1 (en) * 2006-02-24 2007-08-30 Paonan Biotech Co., Ltd. Intervertebral filling
EP1988855A2 (en) * 2006-02-27 2008-11-12 Synthes GmbH Intervertebral implant with fixation geometry
US7918889B2 (en) * 2006-02-27 2011-04-05 Warsaw Orthopedic, Inc. Expandable spinal prosthetic devices and associated methods
US8936872B2 (en) * 2006-03-31 2015-01-20 Zeon Corporation Lithium-ion secondary battery
KR20090007418A (en) 2006-04-12 2009-01-16 스피날모우션, 인코포레이티드 Posterior spinal device and method
US20070270952A1 (en) * 2006-04-19 2007-11-22 Spinal Kinetics, Inc. Prosthetic intervertebral discs implantable by minimally invasive surgical techniques
US20070255406A1 (en) * 2006-04-27 2007-11-01 Sdgi Holdings, Inc. Devices, apparatus, and methods for bilateral approach to disc augmentation
US8133279B2 (en) * 2006-04-27 2012-03-13 Warsaw Orthopedic, Inc. Methods for treating an annulus defect of an intervertebral disc
US20070255286A1 (en) * 2006-04-27 2007-11-01 Sdgi Holdings, Inc. Devices, apparatus, and methods for improved disc augmentation
US20080071379A1 (en) * 2006-05-10 2008-03-20 Mark Rydell Intervertebral disc replacement
US20070280986A1 (en) * 2006-06-01 2007-12-06 Carlos Gil Intra-operative coating of implants
US8187984B2 (en) * 2006-06-09 2012-05-29 Malden Mills Industries, Inc. Temperature responsive smart textile
US20070299201A1 (en) * 2006-06-23 2007-12-27 Replication Medical, Inc. Process for manufacturing hydrogels
US20080004431A1 (en) * 2006-06-30 2008-01-03 Warsaw Orthopedic Inc Method of manufacturing an injectable collagen material
US20080004703A1 (en) * 2006-06-30 2008-01-03 Warsaw Orthopedic, Inc. Method of treating a patient using a collagen material
US8399619B2 (en) 2006-06-30 2013-03-19 Warsaw Orthopedic, Inc. Injectable collagen material
US8118779B2 (en) 2006-06-30 2012-02-21 Warsaw Orthopedic, Inc. Collagen delivery device
US20080026032A1 (en) * 2006-07-27 2008-01-31 Zubery Yuval Composite implants for promoting bone regeneration and augmentation and methods for their preparation and use
US8034110B2 (en) 2006-07-31 2011-10-11 Depuy Spine, Inc. Spinal fusion implant
US20080027554A1 (en) * 2006-07-31 2008-01-31 Talmadge Karen D Kit and methods of treatment of an intervertebral disc
US7758649B2 (en) * 2006-08-04 2010-07-20 Integrity Intellect Inc. Reversibly deformable implant
US20080039942A1 (en) * 2006-08-11 2008-02-14 Bergeron Brian J Spinal implant
JP2008057099A (en) * 2006-08-29 2008-03-13 Mmi-Ipco Llc Temperature responsive smart textile
US8389100B2 (en) * 2006-08-29 2013-03-05 Mmi-Ipco, Llc Temperature responsive smart textile
JP2008057100A (en) * 2006-08-29 2008-03-13 Mmi-Ipco Llc Temperature and moisture responsive smart textile
US8173551B2 (en) * 2006-09-07 2012-05-08 Taiwan Semiconductor Manufacturing Co., Ltd. Defect reduction using aspect ratio trapping
US8715350B2 (en) 2006-09-15 2014-05-06 Pioneer Surgical Technology, Inc. Systems and methods for securing an implant in intervertebral space
WO2008034135A2 (en) 2006-09-15 2008-03-20 Pioneer Surgical Technology, Inc. Joint arthroplasty devices having articulating members
US9278007B2 (en) 2006-09-26 2016-03-08 Spinal Kinetics, Inc. Prosthetic intervertebral discs having cast end plates and methods for making and using them
US8403987B2 (en) 2006-09-27 2013-03-26 Spinal Kinetics Inc. Prosthetic intervertebral discs having compressible core elements bounded by fiber-containing membranes
US9381098B2 (en) * 2006-09-28 2016-07-05 Spinal Kinetics, Inc. Tool systems for implanting prosthetic intervertebral discs
US7557167B2 (en) * 2006-09-28 2009-07-07 Gore Enterprise Holdings, Inc. Polyester compositions, methods of manufacturing said compositions, and articles made therefrom
US8066750B2 (en) 2006-10-06 2011-11-29 Warsaw Orthopedic, Inc Port structures for non-rigid bone plates
US8275594B2 (en) * 2006-10-30 2012-09-25 The Regents Of The University Of Michigan Engineered scaffolds for intervertebral disc repair and regeneration and for articulating joint repair and regeneration
US9439948B2 (en) 2006-10-30 2016-09-13 The Regents Of The University Of Michigan Degradable cage coated with mineral layers for spinal interbody fusion
WO2008063435A1 (en) 2006-11-16 2008-05-29 Rex Medical, L.P. Spinal implant and method of use
US9737414B2 (en) 2006-11-21 2017-08-22 Vertebral Technologies, Inc. Methods and apparatus for minimally invasive modular interbody fusion devices
US8715352B2 (en) 2006-12-14 2014-05-06 Depuy Spine, Inc. Buckling disc replacement
US8663328B2 (en) * 2006-12-21 2014-03-04 Warsaw Orthopedic, Inc. Methods for positioning a load-bearing component of an orthopedic implant device by inserting a malleable device that hardens in vivo
WO2008097616A1 (en) * 2007-02-06 2008-08-14 The Board Of Trustees Of The Leland Stanford Junior University Hydrogel-metal assembly
WO2008103832A2 (en) 2007-02-21 2008-08-28 Benvenue Medical, Inc. Devices for treating the spine
EP2124777A4 (en) 2007-02-21 2013-06-05 Benvenue Medical Inc Devices for treating the spine
US7648521B2 (en) * 2007-03-15 2010-01-19 Zimmer Spine, Inc. System and method for minimally invasive spinal surgery
WO2008124737A2 (en) * 2007-04-10 2008-10-16 Mdesign International Percutaneous delivery and retrieval systems for shape-changing orthopedic joint devices
US20080255664A1 (en) * 2007-04-10 2008-10-16 Mdesign International Percutaneously deliverable orthopedic joint device
US20090012612A1 (en) * 2007-04-10 2009-01-08 David White Devices and methods for push-delivery of implants
EP2339985A4 (en) * 2008-09-12 2013-07-03 Articulinx Inc Tether-based orthopedic joint device delivery methods
US20080269903A1 (en) * 2007-04-25 2008-10-30 Warsaw Orthopedic, Inc. Intervertebral disc nucleus replacement implants and methods
US20080268056A1 (en) * 2007-04-26 2008-10-30 Abhijeet Joshi Injectable copolymer hydrogel useful for repairing vertebral compression fractures
US20080269897A1 (en) * 2007-04-26 2008-10-30 Abhijeet Joshi Implantable device and methods for repairing articulating joints for using the same
KR101464983B1 (en) 2008-05-01 2014-11-25 스파인셀 프러프라이어테리 리미티드 System methods and apparatuses for formation and insertion of tissue prothesis
US20080288074A1 (en) * 2007-05-15 2008-11-20 O'neil Michael J Internally reinforced elastomeric intervertebral disc implants
FR2917287B1 (en) * 2007-06-15 2010-09-03 Ldr Medical intervertebral prosthesis
JP5734650B2 (en) 2007-06-25 2015-06-17 マイクロベンション インコーポレイテッド The self-expanding prosthesis
US20090043391A1 (en) 2007-08-09 2009-02-12 Spinalmotion, Inc. Customized Intervertebral Prosthetic Disc with Shock Absorption
US8323341B2 (en) 2007-09-07 2012-12-04 Intrinsic Therapeutics, Inc. Impaction grafting for vertebral fusion
US20110196492A1 (en) 2007-09-07 2011-08-11 Intrinsic Therapeutics, Inc. Bone anchoring systems
US20090076614A1 (en) * 2007-09-17 2009-03-19 Spinalmotion, Inc. Intervertebral Prosthetic Disc with Shock Absorption Core
CZ301086B6 (en) * 2007-10-17 2009-11-04 Bio-Skin, A. S. Sterile autogenous, allogenic or xenogenic implant and process for preparing thereof
US8758441B2 (en) 2007-10-22 2014-06-24 Spinalmotion, Inc. Vertebral body replacement and method for spanning a space formed upon removal of a vertebral body
US20090149958A1 (en) * 2007-11-01 2009-06-11 Ann Prewett Structurally reinforced spinal nucleus implants
US8122510B2 (en) * 2007-11-14 2012-02-21 Bank Of America Corporation Method for analyzing and managing unstructured data
CA2705684A1 (en) * 2007-11-16 2009-05-22 Synthes Usa, Llc Low profile intervertebral implant
US20090222099A1 (en) * 2008-02-28 2009-09-03 Warsaw Orthopedics, Inc. Self Centering Nucleus Implant
US20090222096A1 (en) * 2008-02-28 2009-09-03 Warsaw Orthopedic, Inc. Multi-compartment expandable devices and methods for intervertebral disc expansion and augmentation
CN102341131A (en) * 2009-03-05 2012-02-01 帝斯曼知识产权资产管理有限公司 Spinal fusion cage
US8469961B2 (en) * 2008-03-05 2013-06-25 Neville Alleyne Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints
US8764833B2 (en) 2008-03-11 2014-07-01 Spinalmotion, Inc. Artificial intervertebral disc with lower height
WO2009117737A2 (en) * 2008-03-21 2009-09-24 Biomimedica, Inc Methods, devices and compositions for adhering hydrated polymer implants to bone
FR2929502B1 (en) * 2008-04-04 2011-04-08 Clariance Implant nucleic.
US9034038B2 (en) 2008-04-11 2015-05-19 Spinalmotion, Inc. Motion limiting insert for an artificial intervertebral disc
US8920491B2 (en) * 2008-04-22 2014-12-30 Boston Scientific Scimed, Inc. Medical devices having a coating of inorganic material
AU2009244382A1 (en) 2008-05-05 2009-11-12 Spinalmotion, Inc. Polyaryletherketone artificial intervertebral disc
US20090297603A1 (en) * 2008-05-29 2009-12-03 Abhijeet Joshi Interspinous dynamic stabilization system with anisotropic hydrogels
US8114156B2 (en) * 2008-05-30 2012-02-14 Edwin Burton Hatch Flexibly compliant ceramic prosthetic meniscus for the replacement of damaged cartilage in orthopedic surgical repair or reconstruction of hip, knee, ankle, shoulder, elbow, wrist and other anatomical joints
US9220603B2 (en) 2008-07-02 2015-12-29 Simplify Medical, Inc. Limited motion prosthetic intervertebral disc
AU2009268687A1 (en) * 2008-07-07 2010-01-14 Biomimedica, Inc Hydrophilic interpenetrating polymer networks derived from hydrophobic polymers
WO2010009151A2 (en) 2008-07-17 2010-01-21 Spinalmotion, Inc. Artificial intervertebral disc placement system
US8172902B2 (en) * 2008-07-17 2012-05-08 Spinemedica, Llc Spinal interbody spacers
EP2299941A1 (en) 2008-07-18 2011-03-30 Spinalmotion Inc. Posterior prosthetic intervertebral disc
US9364338B2 (en) 2008-07-23 2016-06-14 Resspond Spinal Systems Modular nucleus pulposus prosthesis
EP2303196B1 (en) * 2008-07-23 2018-10-24 Marc I. Malberg Modular nucleus pulposus prosthesis
CA2731698A1 (en) 2008-08-05 2010-02-11 Biomimedica, Inc. Polyurethane-grafted hydrogels
JP2012500058A (en) * 2008-08-13 2012-01-05 スメド−ティーエイ/ティーディー・エルエルシー Orthopedic implant having a porous structural member
US9358056B2 (en) 2008-08-13 2016-06-07 Smed-Ta/Td, Llc Orthopaedic implant
US9616205B2 (en) 2008-08-13 2017-04-11 Smed-Ta/Td, Llc Drug delivery implants
US9700431B2 (en) 2008-08-13 2017-07-11 Smed-Ta/Td, Llc Orthopaedic implant with porous structural member
WO2010019781A1 (en) 2008-08-13 2010-02-18 Smed-Ta/Td, Llc Drug delivery implants
US7927375B2 (en) 2008-09-12 2011-04-19 Doty Keith L Dynamic six-degrees-of-freedom intervertebral spinal disc prosthesis
US8814937B2 (en) 2008-09-18 2014-08-26 Peter L. Mayer Intervertebral disc prosthesis, method for assembling, method for implanting prosthesis, and method for explanting
US8187333B2 (en) * 2008-09-18 2012-05-29 Mayer Peter L Intervertebral disc prosthesis and method for implanting and explanting
EP2337526A4 (en) * 2008-10-15 2013-07-31 Replication Medical Inc Swellable interspinous stabilization implant
US20100145460A1 (en) 2008-11-07 2010-06-10 Mcdonough William P Zero-profile interbody spacer and coupled plate assembly
US8226723B2 (en) * 2008-11-20 2012-07-24 Dynatek Laboratories, Inc. Self-retaining artificial spinal disc, and associated methods
US8430930B2 (en) * 2008-12-18 2013-04-30 4-Web, Inc. Truss implant
US8721723B2 (en) 2009-01-12 2014-05-13 Globus Medical, Inc. Expandable vertebral prosthesis
WO2010099256A1 (en) * 2009-02-25 2010-09-02 Replication Medical, Inc. Swellable articulating prosthesis
US8535327B2 (en) 2009-03-17 2013-09-17 Benvenue Medical, Inc. Delivery apparatus for use with implantable medical devices
US20100249932A1 (en) * 2009-03-27 2010-09-30 Warsaw Orthopedic, Inc. Materials, Devices and Methods for Intervertebral Stabilization Via Use of In Situ Shape Recovery
US8636803B2 (en) 2009-04-07 2014-01-28 Spinal Stabilization Technologies, Llc Percutaneous implantable nuclear prosthesis
US8226724B2 (en) * 2009-06-18 2012-07-24 Doty Keith L Intervertebral spinal disc prosthesis
US10016278B2 (en) * 2009-06-30 2018-07-10 Dsm Ip Assets B.V. Biphasic implant device providing joint fluid therapy
US8403988B2 (en) 2009-09-11 2013-03-26 Depuy Spine, Inc. Minimally invasive intervertebral staple distraction devices
US9615933B2 (en) * 2009-09-15 2017-04-11 DePuy Synthes Products, Inc. Expandable ring intervertebral fusion device
US9168138B2 (en) 2009-12-09 2015-10-27 DePuy Synthes Products, Inc. Aspirating implants and method of bony regeneration
AU2010330733A1 (en) * 2009-12-18 2012-08-02 Biomimedica, Inc. Method, device, and system for shaving and shaping of a joint
US8652153B2 (en) 2010-01-11 2014-02-18 Anulex Technologies, Inc. Intervertebral disc annulus repair system and bone anchor delivery tool
GB201002959D0 (en) * 2010-02-22 2010-04-07 Isis Innovation Tissue expander
US8282683B2 (en) 2010-04-12 2012-10-09 Globus Medical, Inc. Expandable vertebral implant
US8870880B2 (en) 2010-04-12 2014-10-28 Globus Medical, Inc. Angling inserter tool for expandable vertebral implant
US9301850B2 (en) 2010-04-12 2016-04-05 Globus Medical, Inc. Expandable vertebral implant
US8591585B2 (en) 2010-04-12 2013-11-26 Globus Medical, Inc. Expandable vertebral implant
US8876870B2 (en) * 2010-04-27 2014-11-04 Adnan Iqbal Qureshi Intraspinal device deployed through percutaneous approach into subarachnoid or intradural space of vertebral canal to protect spinal cord from external compression
US20130217829A1 (en) 2010-08-27 2013-08-22 David Myung "hydrophobic and hydrophilic interpenetrating polymer networks derived from hydrophobic polymers and methods of preparing the same"
US9241809B2 (en) 2010-12-21 2016-01-26 DePuy Synthes Products, Inc. Intervertebral implants, systems, and methods of use
EP2654626B1 (en) 2010-12-21 2016-02-24 Synthes GmbH Intervertebral implants and systems
WO2012155093A1 (en) 2011-05-11 2012-11-15 Microvention, Inc. Device for occluding a lumen
WO2012162552A1 (en) 2011-05-26 2012-11-29 Cartiva, Inc. Tapered joint implant and related tools
US8277505B1 (en) 2011-06-10 2012-10-02 Doty Keith L Devices for providing up to six-degrees of motion having kinematically-linked components and methods of use
US8814873B2 (en) 2011-06-24 2014-08-26 Benvenue Medical, Inc. Devices and methods for treating bone tissue
US20140228867A1 (en) * 2011-09-30 2014-08-14 Covidien Lp Implantable devices having swellable grip members
FR2981263B1 (en) * 2011-10-17 2013-11-15 Clariance Perfectionnments the nucleic silicone implants
EP2782524B1 (en) 2011-11-21 2017-12-20 Biomimedica, Inc Systems for anchoring orthopaedic implants to bone
US8287598B1 (en) 2011-12-05 2012-10-16 TrueMotion Spine, Inc. True spinal motion preserving, shock absorbing, intervertebral spinal disc prosthesis
US9198769B2 (en) 2011-12-23 2015-12-01 Pioneer Surgical Technology, Inc. Bone anchor assembly, bone plate system, and method
US9510953B2 (en) 2012-03-16 2016-12-06 Vertebral Technologies, Inc. Modular segmented disc nucleus implant
US9393126B2 (en) 2012-04-20 2016-07-19 Peter L. Mayer Bilaterally placed disc prosthesis for spinal implant and method of bilateral placement
US9364339B2 (en) 2012-04-30 2016-06-14 Peter L. Mayer Unilaterally placed expansile spinal prosthesis
KR20150060828A (en) 2012-09-25 2015-06-03 4웹, 인코포레이티드 Programmable implants and methods of using programmable implants to repair bone structures
US9737294B2 (en) 2013-01-28 2017-08-22 Cartiva, Inc. Method and system for orthopedic repair
EP2948068A4 (en) 2013-01-28 2016-09-28 Cartiva Inc Systems and methods for orthopedic repair
US10085783B2 (en) 2013-03-14 2018-10-02 Izi Medical Products, Llc Devices and methods for treating bone tissue
US20140277467A1 (en) 2013-03-14 2014-09-18 Spinal Stabilization Technologies, Llc Prosthetic Spinal Disk Nucleus
WO2014159225A2 (en) 2013-03-14 2014-10-02 Baxano Surgical, Inc. Spinal implants and implantation system
US9295479B2 (en) 2013-03-14 2016-03-29 Spinal Stabilization Technologies, Llc Surgical device
WO2014145529A2 (en) 2013-03-15 2014-09-18 4-Web, Inc. Traumatic bone fracture repair systems and methods
US9782270B2 (en) * 2014-08-08 2017-10-10 Warsaw Orthopedic, Inc. Spinal implant system and method
CA2958155A1 (en) * 2014-08-14 2016-02-18 The Secant Group, Llc Composition, methods and devices useful for manufacturing of implantable articles
US9867718B2 (en) 2014-10-22 2018-01-16 DePuy Synthes Products, Inc. Intervertebral implants, systems, and methods of use
AU2016206507A1 (en) 2015-01-16 2017-08-24 Spineovations, Inc. Method of treating spinal disk
WO2016161025A1 (en) 2015-03-31 2016-10-06 Cartiva, Inc. Hydrogel implants with porous materials and methods
US9730773B2 (en) 2015-04-22 2017-08-15 Maxillent Ltd. Bone graft injection methods
US9814496B2 (en) 2015-09-15 2017-11-14 Hydra Medical, LLC Interspinous stabilization implant
RU2634472C2 (en) * 2016-04-22 2017-10-30 Федеральное государственное бюджетное образовательное учреждение высшего образования Московский авиационный институт (национальный исследовательский университет) (МАИ) Endoprosthesis of intervertebral disc nucleus pulposus

Citations (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3875595A (en) * 1974-04-15 1975-04-08 Edward C Froning Intervertebral disc prosthesis and instruments for locating same
US4107121A (en) * 1974-11-25 1978-08-15 Ceskoslovenska Akademie Ved Ionogenic hydrophilic water-insoluble gels from partially hydrolyzed acrylonitrile polymers and copolymers, and a method of manufacturing same
US4220152A (en) * 1978-05-08 1980-09-02 Pfizer Inc. Delivery system
US4309777A (en) * 1980-11-13 1982-01-12 Patil Arun A Artificial intervertebral disc
US4331783A (en) * 1980-09-17 1982-05-25 S.K.Y. Polymers Novel block copolymers including acrylonitrile sequences and glutarimide units and processes for preparing same
US4337327A (en) * 1980-07-07 1982-06-29 S.K.Y. Polymers, Inc. Novel block copolymers including acrylonitrile sequences and sequences including units derived from glutarimide units and processes for preparing same
US4349921A (en) * 1980-06-13 1982-09-21 Kuntz J David Intervertebral disc prosthesis
US4369294A (en) * 1980-09-17 1983-01-18 S.K.Y. Polmers Novel block copolymers including acrylonitrile sequences and glutarimide units and processes for preparing same
US4370451A (en) * 1980-07-07 1983-01-25 S.K.Y. Polymers Novel block copolymers including acrylonitrile sequences and sequences including units derived from glutarimide units and processes for preparing same
US4379874A (en) * 1980-07-07 1983-04-12 Stoy Vladimir A Polymer composition comprising polyacrylonitrile polymer and multi-block copolymer
US4420589A (en) * 1980-07-07 1983-12-13 Stoy Vladimir A Polymer composition including polyacrylonitrile polymers and process for preparing same
US4636217A (en) * 1985-04-23 1987-01-13 Regents Of The University Of Minnesota Anterior spinal implant
US4714469A (en) * 1987-02-26 1987-12-22 Pfizer Hospital Products Group, Inc. Spinal implant
US4759769A (en) * 1987-02-12 1988-07-26 Health & Research Services Inc. Artificial spinal disc
US4772287A (en) * 1987-08-20 1988-09-20 Cedar Surgical, Inc. Prosthetic disc and method of implanting
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4863476A (en) * 1986-08-29 1989-09-05 Shepperd John A N Spinal implant
US4867969A (en) * 1986-02-07 1989-09-19 Alza Corporation Hydrogel formulation for administering non-steroidal drugs
US4904261A (en) * 1987-08-06 1990-02-27 A. W. Showell (Surgicraft) Limited Spinal implants
US4911718A (en) * 1988-06-10 1990-03-27 University Of Medicine & Dentistry Of N.J. Functional and biocompatible intervertebral disc spacer
US4943618A (en) * 1987-12-18 1990-07-24 Kingston Technologies Limited Partnership Method for preparing polyacrylonitrile copolymers by heterogeneous reaction of polyacrylonitrile aquagel
US5047055A (en) * 1990-12-21 1991-09-10 Pfizer Hospital Products Group, Inc. Hydrogel intervertebral disc nucleus
US5053034A (en) * 1990-08-03 1991-10-01 Sven Olerud Spinal joint
EP0505634A1 (en) 1991-03-29 1992-09-30 Kyocera Corporation A prosthesis
US5171280A (en) * 1990-04-20 1992-12-15 Sulzer Brothers Limited Intervertebral prosthesis
US5192326A (en) * 1990-12-21 1993-03-09 Pfizer Hospital Products Group, Inc. Hydrogel bead intervertebral disc nucleus
US5252692A (en) * 1990-11-23 1993-10-12 Kingston Technologies, Inc. Hydrophilic acrylic copolymers and method of preparation
US5489308A (en) * 1989-07-06 1996-02-06 Spine-Tech, Inc. Spinal implant
US5534028A (en) * 1993-04-20 1996-07-09 Howmedica, Inc. Hydrogel intervertebral disc nucleus with diminished lateral bulging
US5674296A (en) * 1994-11-14 1997-10-07 Spinal Dynamics Corporation Human spinal disc prosthesis
US5674295A (en) * 1994-10-17 1997-10-07 Raymedica, Inc. Prosthetic spinal disc nucleus
US5676701A (en) * 1993-01-14 1997-10-14 Smith & Nephew, Inc. Low wear artificial spinal disc
US5716415A (en) * 1993-10-01 1998-02-10 Acromed Corporation Spinal implant
US5824094A (en) * 1997-10-17 1998-10-20 Acromed Corporation Spinal disc
US5824093A (en) * 1994-10-17 1998-10-20 Raymedica, Inc. Prosthetic spinal disc nucleus
US5863551A (en) * 1996-10-16 1999-01-26 Organogel Canada Ltee Implantable polymer hydrogel for therapeutic uses
US5879385A (en) * 1993-06-11 1999-03-09 Hillway Surgical Limited Surgical implant
US5976186A (en) * 1994-09-08 1999-11-02 Stryker Technologies Corporation Hydrogel intervertebral disc nucleus
US6110210A (en) * 1999-04-08 2000-08-29 Raymedica, Inc. Prosthetic spinal disc nucleus having selectively coupled bodies
WO2000064385A1 (en) 1999-04-26 2000-11-02 Li Medical Technologies, Inc. Prosthetic apparatus and method
US6165225A (en) * 1995-10-13 2000-12-26 Islet Sheet Medical Llc Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change, processes for their manufacture, and methods for their use
US6264695B1 (en) * 1999-09-30 2001-07-24 Replication Medical, Inc. Spinal nucleus implant
WO2002076336A2 (en) 2001-03-22 2002-10-03 Keraplast Technologies, Ltd. Implantable prosthetic or tissue expanding device
US20020183848A1 (en) * 1999-04-05 2002-12-05 Raymedica, Inc. Prosthetic spinal disc nucleus having a shape change characteristic
US20030023311A1 (en) * 2000-08-30 2003-01-30 Trieu Hai H. Intervertebral disc nucleus implants and methods
US7004971B2 (en) * 2002-12-31 2006-02-28 Depuy Acromed, Inc. Annular nucleus pulposus replacement
US7368862B2 (en) * 1999-07-20 2008-05-06 Sri International Electroactive polymer generators

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292695A (en) * 1980-06-25 1981-10-06 Lord Corporation Prosthesis stem
US4366901A (en) * 1981-02-02 1983-01-04 Medtronic, Inc. In situ rehydrating in sterile packages
US5522898A (en) * 1993-09-16 1996-06-04 Howmedica Inc. Dehydration of hydrogels
GB9413855D0 (en) * 1994-07-08 1994-08-24 Smith & Nephew Prosthetic devices
US5674269A (en) * 1995-02-06 1997-10-07 Augustine Medical, Inc. Patient warming system with user-configurable access panel
US5834094A (en) 1996-09-30 1998-11-10 Surface Technologies Ltd. Bearing having micropores and design method thereof
US6533817B1 (en) * 2000-06-05 2003-03-18 Raymedica, Inc. Packaged, partially hydrated prosthetic disc nucleus
DE60101967T2 (en) * 2000-07-03 2004-07-22 Osteotech, Inc. Bone-forming implant from bone

Patent Citations (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3875595A (en) * 1974-04-15 1975-04-08 Edward C Froning Intervertebral disc prosthesis and instruments for locating same
US4107121A (en) * 1974-11-25 1978-08-15 Ceskoslovenska Akademie Ved Ionogenic hydrophilic water-insoluble gels from partially hydrolyzed acrylonitrile polymers and copolymers, and a method of manufacturing same
US4220152A (en) * 1978-05-08 1980-09-02 Pfizer Inc. Delivery system
US4349921A (en) * 1980-06-13 1982-09-21 Kuntz J David Intervertebral disc prosthesis
US4379874A (en) * 1980-07-07 1983-04-12 Stoy Vladimir A Polymer composition comprising polyacrylonitrile polymer and multi-block copolymer
US4420589A (en) * 1980-07-07 1983-12-13 Stoy Vladimir A Polymer composition including polyacrylonitrile polymers and process for preparing same
US4337327A (en) * 1980-07-07 1982-06-29 S.K.Y. Polymers, Inc. Novel block copolymers including acrylonitrile sequences and sequences including units derived from glutarimide units and processes for preparing same
US4370451A (en) * 1980-07-07 1983-01-25 S.K.Y. Polymers Novel block copolymers including acrylonitrile sequences and sequences including units derived from glutarimide units and processes for preparing same
US4369294A (en) * 1980-09-17 1983-01-18 S.K.Y. Polmers Novel block copolymers including acrylonitrile sequences and glutarimide units and processes for preparing same
US4331783A (en) * 1980-09-17 1982-05-25 S.K.Y. Polymers Novel block copolymers including acrylonitrile sequences and glutarimide units and processes for preparing same
US4309777A (en) * 1980-11-13 1982-01-12 Patil Arun A Artificial intervertebral disc
US4636217A (en) * 1985-04-23 1987-01-13 Regents Of The University Of Minnesota Anterior spinal implant
US4867969A (en) * 1986-02-07 1989-09-19 Alza Corporation Hydrogel formulation for administering non-steroidal drugs
US4863476A (en) * 1986-08-29 1989-09-05 Shepperd John A N Spinal implant
US4759769A (en) * 1987-02-12 1988-07-26 Health & Research Services Inc. Artificial spinal disc
US4714469A (en) * 1987-02-26 1987-12-22 Pfizer Hospital Products Group, Inc. Spinal implant
US4904261A (en) * 1987-08-06 1990-02-27 A. W. Showell (Surgicraft) Limited Spinal implants
US4772287A (en) * 1987-08-20 1988-09-20 Cedar Surgical, Inc. Prosthetic disc and method of implanting
US4904260A (en) * 1987-08-20 1990-02-27 Cedar Surgical, Inc. Prosthetic disc containing therapeutic material
US4943618A (en) * 1987-12-18 1990-07-24 Kingston Technologies Limited Partnership Method for preparing polyacrylonitrile copolymers by heterogeneous reaction of polyacrylonitrile aquagel
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4911718A (en) * 1988-06-10 1990-03-27 University Of Medicine & Dentistry Of N.J. Functional and biocompatible intervertebral disc spacer
US5489308A (en) * 1989-07-06 1996-02-06 Spine-Tech, Inc. Spinal implant
US5171280A (en) * 1990-04-20 1992-12-15 Sulzer Brothers Limited Intervertebral prosthesis
US5053034A (en) * 1990-08-03 1991-10-01 Sven Olerud Spinal joint
US5252692A (en) * 1990-11-23 1993-10-12 Kingston Technologies, Inc. Hydrophilic acrylic copolymers and method of preparation
US5192326A (en) * 1990-12-21 1993-03-09 Pfizer Hospital Products Group, Inc. Hydrogel bead intervertebral disc nucleus
US5047055A (en) * 1990-12-21 1991-09-10 Pfizer Hospital Products Group, Inc. Hydrogel intervertebral disc nucleus
EP0505634A1 (en) 1991-03-29 1992-09-30 Kyocera Corporation A prosthesis
US5676701A (en) * 1993-01-14 1997-10-14 Smith & Nephew, Inc. Low wear artificial spinal disc
US5534028A (en) * 1993-04-20 1996-07-09 Howmedica, Inc. Hydrogel intervertebral disc nucleus with diminished lateral bulging
US5879385A (en) * 1993-06-11 1999-03-09 Hillway Surgical Limited Surgical implant
US5716415A (en) * 1993-10-01 1998-02-10 Acromed Corporation Spinal implant
US5976186A (en) * 1994-09-08 1999-11-02 Stryker Technologies Corporation Hydrogel intervertebral disc nucleus
US5674295A (en) * 1994-10-17 1997-10-07 Raymedica, Inc. Prosthetic spinal disc nucleus
US5824093A (en) * 1994-10-17 1998-10-20 Raymedica, Inc. Prosthetic spinal disc nucleus
US5674296A (en) * 1994-11-14 1997-10-07 Spinal Dynamics Corporation Human spinal disc prosthesis
US5865846A (en) * 1994-11-14 1999-02-02 Bryan; Vincent Human spinal disc prosthesis
US6165225A (en) * 1995-10-13 2000-12-26 Islet Sheet Medical Llc Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change, processes for their manufacture, and methods for their use
US5863551A (en) * 1996-10-16 1999-01-26 Organogel Canada Ltee Implantable polymer hydrogel for therapeutic uses
US5824094A (en) * 1997-10-17 1998-10-20 Acromed Corporation Spinal disc
US20020183848A1 (en) * 1999-04-05 2002-12-05 Raymedica, Inc. Prosthetic spinal disc nucleus having a shape change characteristic
US6110210A (en) * 1999-04-08 2000-08-29 Raymedica, Inc. Prosthetic spinal disc nucleus having selectively coupled bodies
WO2000064385A1 (en) 1999-04-26 2000-11-02 Li Medical Technologies, Inc. Prosthetic apparatus and method
US6764514B1 (en) * 1999-04-26 2004-07-20 Sdgi Holdings, Inc. Prosthetic apparatus and method
US7368862B2 (en) * 1999-07-20 2008-05-06 Sri International Electroactive polymer generators
US6264695B1 (en) * 1999-09-30 2001-07-24 Replication Medical, Inc. Spinal nucleus implant
US7204897B2 (en) * 1999-09-30 2007-04-17 Replication Medical, Inc. Hydrogel-based prosthetic device for replacing at least a part of the nucleus of a spinal disc
US20030023311A1 (en) * 2000-08-30 2003-01-30 Trieu Hai H. Intervertebral disc nucleus implants and methods
WO2002076336A2 (en) 2001-03-22 2002-10-03 Keraplast Technologies, Ltd. Implantable prosthetic or tissue expanding device
US7004971B2 (en) * 2002-12-31 2006-02-28 Depuy Acromed, Inc. Annular nucleus pulposus replacement

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Hudgins, R. Garryl, and Muzzy, John D., Polymer Composites, vol. 19, No. 6, 1998, pp. 837-845.
Hudgins, Robert Garryl, Development and Characterization of a Prosthetic Intervertebral Disc, Published Aug. 16, 1999 (on information and belief); Copyright 1998, ISBN 978-0-599-17460-3.

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120116514A1 (en) * 2002-11-05 2012-05-10 Kuslich Stephen D Semi-biological intervertebral disc replacement system
US20120232575A1 (en) * 2006-06-12 2012-09-13 Wirtel Iii Anthony Inflatable multi-chambered devices and methods of treatment using the same
US8460383B2 (en) * 2006-06-12 2013-06-11 Globus Medical, Inc. Inflatable multi-chambered devices and methods of treatment using the same
US10278829B2 (en) 2006-06-12 2019-05-07 Globus Medical, Inc. Inflatable multi-chambered devices and methods of treatment using the same
US20100222881A1 (en) * 2008-10-03 2010-09-02 Ann Prewett Vessel protection device
US20110224790A1 (en) * 2009-09-11 2011-09-15 Articulinx, Inc. Disc-based orthopedic devices
US8292954B2 (en) * 2009-09-11 2012-10-23 Articulinx, Inc. Disc-based orthopedic devices
US8764830B2 (en) 2009-09-11 2014-07-01 Articulinx, Inc. Disc-shaped orthopedic devices
US20130282121A1 (en) * 2012-03-22 2013-10-24 Ann Prewett Spinal facet augmentation implant and method

Also Published As

Publication number Publication date
EP1231868B8 (en) 2011-10-19
US6264695B1 (en) 2001-07-24
US20030055506A1 (en) 2003-03-20
JP4347539B2 (en) 2009-10-21
AU768903B2 (en) 2004-01-08
EP1231868B1 (en) 2011-06-15
US6726721B2 (en) 2004-04-27
JP2003510129A (en) 2003-03-18
US7204897B2 (en) 2007-04-17
CA2388794A1 (en) 2001-04-05
CA2388794C (en) 2008-12-30
US20050171611A1 (en) 2005-08-04
EP1231868A2 (en) 2002-08-21
WO2001022902A9 (en) 2009-01-08
ES2367626T3 (en) 2011-11-07
CZ20021137A3 (en) 2002-09-11
WO2001022902A2 (en) 2001-04-05
AU7843200A (en) 2001-04-30
AT512643T (en) 2011-07-15
EP1231868A4 (en) 2010-01-06
WO2001022902A3 (en) 2001-10-25

Similar Documents

Publication Publication Date Title
US6783546B2 (en) Implantable prosthetic or tissue expanding device
JP4105721B2 (en) Intervertebral disc nucleus pulposus prosthesis for percutaneous implantation
US6602291B1 (en) Prosthetic spinal disc nucleus having a shape change characteristic
EP2173792B1 (en) Multi-polymer hydrogels
US6974479B2 (en) System and method for blocking and/or retaining a prosthetic spinal implant
KR100626248B1 (en) Packaged, partially hydrated prosthetic disc nucleus
FI78394C (en) Biologically laempliga, antitrombogena material Foer tillaempning at rekonstrionskirurgi.
CA2632189C (en) Mechanical apparatus and method for artificial disc replacement
JP4317659B2 (en) The implantable tissue repair device
EP0304305A1 (en) Prosthetic disc
US8895073B2 (en) Hydrogel implant with superficial pores
AU782208B2 (en) Associating hydrogels for nucleus pulposus replacement in intervertebral discs
CA2548661C (en) Compressed high density fibrous polymers suitable for implant
NL1023926C2 (en) A prosthesis on the basis of a fiber-reinforced hydrogel and method for the manufacture of the prosthesis and its use.
US7618461B2 (en) Composite intervertebral disc implants and methods for forming the same
US20100318108A1 (en) Composite mesh devices and methods for soft tissue repair
CA2799196C (en) Porous materials, methods of making and uses
US20100016907A1 (en) Replacement or supplementation of a nucleus pulposus using a hydrogel
DK2571543T3 (en) Porous materials concern methods of making and uses
US6893466B2 (en) Intervertebral disc nucleus implants and methods
US5391203A (en) Method of draining and filling soft tissue implant
AU605723B2 (en) Prosthetic meniscus
US7503936B2 (en) Methods for forming and retaining intervertebral disc implants
AU597811B2 (en) Semipermeable nerve guidance channels
JP3007903B2 (en) Artificial disc

Legal Events

Date Code Title Description
AS Assignment

Owner name: REPLICATION MEDICAL, INC., NEW JERSEY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GONTARZ, GERALD;REEL/FRAME:019181/0487

Effective date: 20070208

CC Certificate of correction
FPAY Fee payment

Year of fee payment: 12